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The widespread use of pesticides by farmers, pest control operators and 
even the general public can pose significant risks to children's health. One 
particular pesticide, chlorpyrifos, was the most widely used pesticide in the 
United States with total use estimated at approximately 30 million pounds per 
year. Young children and the developing fetus are far more susceptible to the 
effects of pesticide exposure as a result of unusual exposure patterns and 
developmental immaturities. Transplacental transfer and lactational exposure are 
the pathways exclusive to the developing fetus and infant. Chlorpyrifos exposure 
is of special concern in this population because of its potential for disruption of 
normal brain function and cognitive development. 
The purpose of this study was to determine the concentration of 
chlorpyrifos in three different biological specimens: breast milk, plasma, and 
saliva. The research method employed for this study was a secondary analysis of 
existing samples collected for the purposes of a prior study. Based on specimen 
availability, there were a total of 26 subjects each for the lactating group and the 
non-lactating group. The lactation group had 26 matched breast milk, plasma and 
saliva samples and the non-lactation group had 26 matched plasma and saliva 
samples. The biological specimens were tested in the laboratory using an assay 
specific to chlorpyrifos. The Chlorpyrifos RaPID Assay was developed by 
Strategic Diagnostics, Inc and had a detection limit of 0.1 ng/ml (ppb) and a 
linear range of 0.22 to 3.0 ng/ml (ppb). 
v 
Overall, for the lactation group, 25/26 samples were positive for 
chlorpyrifos with milk concentrations significantly higher than plasma or salivary 
concentrations. 19126 plasma samples were positive and 10/26 saliva samples 
were positive for chlorpyrifos. For the non-lactation group, 23/26 plasma samples 
were positive for chlorpyrifos and 16/26 saliva samples were positive. In addition, 
the plasma chlorpyrifos concentrations were significantly higher than salivary 
concentrations in the non-lactation group. Comparing the two groups, salivary 
chlorpyrifos concentrations were significantly higher in the lactation group. 
There is mounting evidence of pesticide contamination in the breast milk 
of lactating women. This study has contributed to this knowledge by documenting 
chlorpyrifos concentrations in breast milk, plasma, and saliva of lactating and 
non-lactating mothers. However, further research needs to be done to determine 
what these chemicals are doing to our children. 
vi 
TABLE OF CONTENTS 

Chapter ................................................................................................ Page 







Chlorpyrifos .......................................................................... 8 

Exposure Assessment ................................................................... 11 

Lactational transfer pathway .............................................. 12 

Effects Assessment ....................................................................... 18 

Statement of the Problem .............................................................. 23 

Purpose of the Study ..................................................................... 24 

Theoretical Framework .................................................................. 25 

Delimitations .................................................................................. 31 





II. LITERATURE REVIEW ....................................................................... 33 

Exposure Assessment ................................................................... 33 

Oral exposure .................................................................... 33 

Dermal exposure ................................................................ 37 

Inhalation exposure ............................................................ 39 

Take-home exposure .........................................................41 

Transplacental exposure .................................................... 42 

Lactational exposure .......................................................... 46 

Biomarkers of Exposure................................................................. 51 





III. METHODS .......................................................................................... 59 

Study Design .................................................................................. 59 





Setting ............................................................................................ 64 

Protection of Human Rights ...........................................................64 

Instruments .................................................................................... 65 

Data Collection ...............................................................................71 





IV. RESULTS ........................................................................................... 75 

Sample Demographics ................................................................... 75 

Lactating Group ............................................................................. 80 







V. DiSCUSSiON ...................................................................................... 92 

Non-lactating Group ...................................................................... 1 02 

Summary ...................................................................................... 1 07 

Lactating Group ............................................................................. 96 

Nursing Implications .....................................................................105 

Future Studies ..............................................................................106 












Table 	 Page 
1. Demographic statistics for lactating group ............................... 78 

2. Demographic statistics for non-lactating group ........................ 79 

3. 	 Statistics for biological samples in lactating group ................... 81 

4. 	 Spearman Rho Correlation matrix for lactating group .............. 81 

5. 	 Significance of difference in milk and plasma/saliva 

chlorpyrifos ............................................................................. 84 

6. 	 Statistics for lactating group ..................................................... 85 

7. 	 Statistics for biological samples in non-lactating group ............ 86 

8. 	 Spearman Rho Correlation matrix for non-lactating group ....... 88 

9. 	 Significance of difference in plasma chlorpyrifos ..................... 89 

10. 	 Statistics for non-lactating group .............................................. 90 

11. 	 Statistics for lactating and non-lactating groups ....................... 91 

12. 	 Significance of difference in salivary chlorpyrifos ..................... 91 

ix 
LIST OF FIGURES 

Figure 	 Page 
1. 	 The metabolic activation from chlorpyrifos to chlorpyrifos oxon ..... 20 

2. 	 Conceptual model by Dixon and Dixon .......................................... 28 

3. 	 Conceptual model by Casey .......................................................... 30 

4. 	 Milk chlorpyrifos concentration in parts per billion (ppb) ............... 76 

5. 	 Plasma chlorpyrifos concentration in parts per billion (ppb) ...........76 

6. 	 Saliva chlorpyrifos concentration in parts per billion (ppb)............ 77 

7. 	 Positive relationship of milk chlorpyrifos concentration in parts per 

billion (ppb) and live births ............................................................. 82 

8. 	 Positive relationship of plasma chlorpyrifos concentration in parts 

per billion (ppb) and height ............................................................ 82 

9. 	 Positive relationship of milk and plasma chlorpyrifos concentration 

in parts per billion (ppb) ................................................................. 83 

10. 	 Negative relationship of plasma chlorpyrifos concentration in 

parts per billion (ppb) and live births .............................................. 88 

11. 	 Negative relationship of plasma chlorpyrifos concentration in 












The widespread use of pesticides by farmers, pest control operators and 
even the general public can pose significant risks to human health, especially 
children. One particular pesticide, chlorpyrifos, is the most widely used pesticide 
in the United States with total use estimated at approximately 30 million pounds 
per year (EWG, 1998). Young children and the developing fetus are far more 
susceptible to the effects of pesticide exposure as a result of unusual exposure 
patterns and developmental immaturities. Transplacental transfer and lactational 
exposure are the pathways exclusive to the developing fetus and infant 
(Byczkowski, Kacew, Miller, Pelkoneu & Saunders, 2001). Because brain growth 
is very rapid prior to and following birth, chlorpyrifos exposure is of special 
concern in this population because of its potential for disruption of normal brain 
growth function and cognitive development. There is mounting concern that 
repeated low-level exposure to organophosphorus pesticides in utero or 
postnatally increases the risk of poor performance on neurobehavioral and 
cognitive examinations during infancy and childhood (Olson, Blank, & Menton, 
1998; Weiss & Landrigan, 2000). 
Pesticides 
Pesticides, which include insecticides, herbicides, and fungicides, are 
regulated under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). 
This was the first attempt to address the potential risks to human health posed by 
pesticide products. The act directs the Environmental Protection Agency (EPA) to 
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restrict the use of pesticides as necessary to prevent unreasonable adverse 
effects on people and the environment and prohibits the sale of any pesticide in 
the US unless it is registered and labeled according to appropriate uses and 
restrictions. This law specifies that a pesticide may not be marketed until the EPA 
has registered it. To register a pesticide as an active ingredient, pesticide 
product, or a new use of a registered pesticide, The EPA requires submission of 
scientific data on pesticide toxicity and behavior in the environment (this may 
require data from any combination of more than 100 different tests, depending on 
the toxicity and degree of exposure). 
Toxicity studies are required to assess the potential hazards to humans 
through varying degrees of exposure (acute, sub-chronic, and chronic) of lab 
animals to pesticides. Acute toxicity studies provide information on short-term 
exposures. The first step evaluates oral, dermal, and inhalation toxicities. Sub­
chronic (90 day) studies provide information on toxicities that may be a result of 
repeated exposures to a pestiCide over a period up to 30% of the lifetime of a 
rodent. Chronic (1 to 2 year) studies provide information on toxicities that occur 
over a large portion of the life span with particular emphasis on carcinogenicity or 
tumor development. Unfortunately, the EPA does not routinely require 
neurodevelopmental toxicity testing or functional assessment of the nervous 
system, even on neurotoxic chemicals (Wallinga, 1998). Nor do they require 
lifetime testing of those animals exposed in utero or infancy to assess for 
diseases that might develop later in life. A pesticide is subjected to close scrutiny 
if the EPA concludes that the chemical poses a significant risk to humans based 
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on animal studies. However, even if a pesticide is convincingly shown to be 
teratogenic, the law allows the chemical to be registered if the economic benefits 
outweigh the risk (Chaffrey, 2000). 
Due to the increasing environmental concerns and the vulnerabilities of 
developing infants and children, Congress specifically requested that the EPA 
increase the stringency of its requirements for neurotoxic and behavioral testing 
on prenatal and neonatal animals (Merrill, 2001). Of the 800,000 pesticides on 
the market, only a few have been evaluated for their cumulative effects on 
children, and most of the 140 neurotoxic pesticides have not been tested 
(Anderson, Nielsen, & Grandjean, 2000). The EPA advisory committee has 
recently identified organophosphate insecticide effects as one of the five areas 
where children's vulnerabilities have not been adequately assessed by existing 
EPA regulations (Wigle, 2003). 
Because humans are exposed to a variety of chemicals in the 
environment, US Supreme Court validated the need for a method to determine 
the inherent health risks associated with chemical exposure. Together with 
Federal Regulatory Agencies, a framework was developed. This was known as 
Risk Assessment in the Federal Government: Managing the Process (or simply 
the Red Book). Risk assessment is defined as the systematic scientific 
characterization of potential adverse health effects resulting from human 
exposure to hazardous agents (Hooper, 1989). Because all chemical risk 
assessment scenarios are not the same, the risk assessment process provides a 





This process involves four steps: hazard identification, dose-response 
assessment, exposure assessment, and risk characterization or effects 
assessment (Faustman & Omenn, 2001). 
Hazard identification involves the toxicity assessment of chemicals and 
whether they have the ability to produce adverse health effects in animals or 
humans. This can involve structure-activity analysis, animal bioassays, and 
epidemiological approaches. Structure activity relationships (SARS) predict toxic 
properties from information on molecular structure with the concept that if a 
particular chemical is known to be a carcinogen then another chemical with the 
same molecular structure will also be a carcinogen (Gramatica, 2004). Lifetime 
animal assays were developed as a gold standard to establish such end points 
as carcinogenicity or teratogenicity. The premise with this test was that it would 
be extrapolated to humans. The most convincing hazard assessment approach 
involves the use of epidemiological studies to assess the correlation between 
exposure and disease. 
The second step of the risk assessment process is that of the chemical 
toxicity or dose-response assessment. This step is important in determining 
where on the dose-response curve an adverse health effect is expected to occur 
or. Sometimes it is used to determine the safe exposure level that is sufficiently 
small enough not to cause any adverse human health effects. The threshold 
dose is the dose below, which no change in biological response occurs, followed 
by the no observed adverse effect level (NOAEL) and the lowest observed 
adverse effect level (LOAEL). 
4 

The exposure assessment involves a quantitative estimation of the 
environmental exposure and the subsequent entry into the human body. This 
assessment addresses three areas: the exposure (the number of people 
exposed at specific concentrations for the time period of interest), the resulting 
dose, and the cause (the contribution of important sources and pathways to 
exposure or dose) (Sexton et ai, 1995). The primary goal is not only to determine 
the amount of exposure but also to find out how much of a specific agent may be 
reaching target organs in the body. 
Risk characterization is the final step in the risk assessment and is also 
know as the effects assessment. This step utilizes all of the information obtained 
in the previous three previous quantitative methods to provide a qualitative 
conclusion of the likelihood that a particular chemical is able to produce adverse 
health effects and is therefore, a human health hazard (Sexton et ai, 1995). 
Other questions addressed in risk characterization include: what is the nature 
and estimated incidence of adverse effects in a given population and how robust 
is the evidence? 
Because there are so many inherent assumptions and extrapolations 
being made, the risk assessment process can be a source of uncertainty versus 
actuality. Although some believe that the predominant problem with the risk 
assessment is over exaggeration or risk estimates, the majority of scientists, 
toxicologists, and regulatory agencies believe that there are flaws in the process 
that need to be improved. The extrapolation process is considered a weakness 




Extrapolations may be from one species to another or within the same species, 
from one route of exposure in one species to a different route of exposure in 
another species, and from continuous exposure conditions in the laboratory to 
varying human exposures in the environment. Although the debate over the risk 
assessment is well founded due to the potential inadequacies and uncertainties, 
the process does provide valuable environmental toxicological information on 
potential human health hazards. 
Insecticides. Insecticides are classified according to three major 
categories, the organochlorides, the pyrethroids, and the anticholinesterase 
agents. The differences between the effects of these various chemicals relate 
primarily to their ability to interfere with the membrane transport of sodium, 
potassium, calcium, or chloride; ability to inhibit enzyme activities; or the ability to 
inhibit the breakdown of neurotransmitters at nerve endings (Ecobichon, 2001). 
The United States government banned several chemicals in the organochloride 
class because of their high toxicity potential. The year 1962 was known as the 
"Silent Spring" because of one such chemical. DDT, one of the most powerful 
pesticides the world has ever known, was developed in 1939 to protect U.S. 
troops from malaria in the South Pacific Islands. The inventor was awarded the 
Nobel Prize. It became available for civilian use in 1945. Thirteen years later, a 
marine biologist with the U.S. Fish and Wildlife Service received a letter from a 
friend outlining the dangers associated with DDT sprayings. It took four years for 
Rachel Carson to complete the book entitled "Silent Spring". The book 
meticulously described the sequential effects associated with DDT sprayings. 
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Following a single crop application of DDT, it remained toxic in the environment 
for years even after it was diluted by rainwater. Not only was DDT killing insects 
but also fish, birds and eventually up the food chain to humans and thereby 
contaminating the entire world food supply. The book's final chapter illustrates a 
nameless American town where all life, from fish to birds to apples to human 
children, had been silenced by the insidious effects of DDT (Carson, 1962). As a 
result, the EPA banned the use of DDT in 1972. In the late 1980's the EPA also 
banned other highly toxic organochlorine chemicals like Aldrin, Dieldrin, and 
Chlordane. 
The anticholinesterase insecticides include two chemical classes, the 
carbamates and the organophosphates. These particular chemicals have 
become widely used as replacements for the more persistent organochlorides 
but are receiving more attention because of their acute neurobehavioral effects. 
Carbamates are primarily used in vector control on lawns and gardens. They are 
part of a large group of synthetic pesticides that have been developed in the last 
40 years. 
The organophosphates were first developed for agricultural use for the 
control of insects. Their acute lethality is due to their ability to inhibit an enzyme 
that is vital to normal nerve function. Subsequently, organophosphates have 
been used on humans as well. The Germans used them in WWII as chemical 
warfare agents (Ecobichon, 1997). Japanese terrorists used them as nerve 
agents in a Tokyo subway in 1995, and there have been concerns of possible 




The organophosphates are esters of phosphoric or phosphorothioic acids 
with R1. R2, and R3 substituents directly to or through an oxygen to the 
phosphorus carbon. These substituents can include the alkyl, alkoxy, or aryl 
groups (Chambers, 1992). Metabolism occurs chiefly by hydrolysis in the liver. 
Since the breakdown is relatively slow, significant storage in body fat may occur. 
Some organophosphates are extremely lipid soluble allowing them to be stored 
in fat with subsequent delayed toxicity due to late release (Ecobichon, 2001). 
There are direct and indirect organophosphate inhibitors. Those that are 
direct (parathion, diazinon, malathion, and chlorpyrifos) require metabolic 
activation before they can inhibit acetylcholinesterase. This activation is 
accomplished by the conversion from a thion (P=S) to an oxon (P=O) by the 
action of the liver microsomes utilizing the cytochrome P450 enzymes (Vale, 
1998). Oxidative desulfuration results in the formation of the oxon of the parent 
compound. Ultimately, both thions and oxons are hydrolyzed at the ester linkage, 
yielding alkyl phosphates and leaving groups, which are then either excreted or 
further transformed in the body (Ecobichon, 1997). 
Chlorpyrifos. This very common organophosphate gained popularity in 
1965 because of the decreased availability of chemicals in the organochlorine 
class. In the mid 1990's, chlorpyrifos was ranked 12th in frequency of indoor 
pesticide applications and 5th in frequency of outdoor pesticide applications 
(Robinson, Pease &Albright, 1994). According to the NHEXAS study by Sexton 
et al (1995) and the Minnesota Children's Pesticide study by Quackenboss et al 
(2000), the majority of the U.S. population is exposed to chlorpyrifos. These 
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epidemiological studies reported measurable concentrations of TCP (3, 5, 6­
trichlor0-2-pyridinol), the primary urinary metabolite of chlorpyrifos, in 82°k of 993 
adults and 92% of children. Chlorpyrifos residues were also found in air samples 
in 83-97°k of homes in Florida and in 30-40% of homes in Massachusetts 
(Whitmore, Immerman, Camann, Bond, Lewis & Schaum, 1994). There are 
approximately 822 registered products containing chlorpyrifos on the market that 
are applied in and around homes more than 20 million times a year in the United 
States (Steenland, Dick, Howell, Chrislip, Hines, & Reed, 2000). Manufacturers 
of chlorpyrifos earn a reported $350 million a year from chlorpyrifos sales in the 
United States, not including exports sales to over 88 countries. 
Agriculturally, chlorpyrifos is used on a variety of food crops such as citrus 
crops, vegetable crops, and tree fruits. It is also used as a mosquitocide and as 
an insecticidal ear tag for cattle. Professionally, chlorpyrifos is used in residential 
and commercial buildings, schools, daycare centers, hotels, restaurants, 
hospitals, and food manufacturing plants. The majority of urban use is involved in 
termite control around baseboards. It is also injected into cracks and crevices for 
roach control and as a broadcast application in the treatment of fleas. 
The most common use of this pesticide occurs in the home by the so­
called "do-it-yourselfers" as it can be found under the sinks or in the garages of 
most homes. Chlorpyrifos-containing products are used in the kitchen, bathroom, 
and other living spaces (Whitmore, Kelly, & Reading, 1992). It is used as a spray 
to kill roaches or ants, and it is used as a fogger to get rid of fleas. Such products 
include: Black Flag Roach and Ant Killer, Ortho Home Pest Insect Control and 
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Lawn Insect Spray, Raid Ant Controller and Home Insect Killer Formula, 
Sergeant's Fast-Acting Flea and Tick Collar, and Hartz 30 Day Flea and Tick 
Collar for Dogs. Indoor use by unlicensed or untrained applicators has resulted in 
excessive human exposure with most of the incidents occurring as a result of 
misuse (Blondell, Suhre & Smegal, 1999). Among the general population, people 
who use the insecticide in homes and gardens and people who ingest food 
exposed to chlorpyrifos are at higher risks of exposure (U.S. Department of 
Health and Human Services, 1997). 
Chlorpyrifos, [0, O-diethyl 0- (3, 5, 6-trichloro-2-pyridinyl)­
phosphorothionate] is a broad-spectrum organophosphate insecticide. It acts 
primarily as a contact poison and is available in a variety of formulations 
(granules, powder, and liquid spray). Chlorpyrifos enters the environment as a 
result of its widespread use as an insecticide. It is released into the air by 
volatilization during foliage or soil application or by broadcast application. 
Chlorpyrifos is considered a moderately volatile chemical meaning that it will 
exist primarily in the vapor phase but will also partition to available airborne 
particulate suggesting that it may travel long distances in the air (Racke, 1993). 
Chlorpyrifos is considered to be practically insoluble in water, but 
persistence in water has been measured between 35 and 140 days (McDougall, 
Wan & Harris, 1994). It has a strong tendency to partition into the soil and 
sediment and has an affinity for sorption. Once in the soil, chlorpyrifos degrades 
under ultraviolet light via chemical hydrolysis and by the action of soil microbes. 
The persistence of chlorpyrifos in soil metabolism half-life ranges from 11 to 180 
10 

days; however, much longer soil half-lives of 175 to 1576 days has been reported 

following termiticide applications (Howard, 1991). Once in the environment, 

chlorpyrifos can then accumulate into living creatures resulting in 

bioaccumulation up the food chain. Chlorpyrifos has been found to be extremely 

toxic to freshwater fish (Srivasta, Tiwari & Srivastava, 1990), birds (Simpson, 

1984), cats (Jaggy & Oliver, 1990), and monkeys (Brack & Rothe, 1982). 

Exposure Assessment 
Chlorpyrifos exposure can occur through several pathways. Oral exposure 
occurs through the ingestion of residues on food crops, fish, meat, or dairy 
products. The U.S. Food and Drug Administration (1994) found that chlorpryifos 
was the fifth most common detected pesticide on food crops. Chlorpyrifos 
residues have been found in channel catfish following waterborne exposure 
(Barron, Plakas &Wilga, 1991). Residues have also been found in beef (Ivey, 
Mann &Oehler, 1972) and pork (Ivey &Palmer, 1979) following treatment for 
ticks and lice. In all cases fat appeared to have higher chlorpyrifos concentrations 
than other tissues (Cox, 1995). Residues were also found in dairy cow milk and 
cream (McKellar, 1976). 
Dermal exposure can occur through skin contact with contaminated 
surfaces. Chlorpyrifos residues were detectable on soft, absorbent surfaces, 
such as stuffed toys, furniture, and carpet for up to two weeks following a fogging 
application (Gurnunathan, Freeman, Buckley, Roy, Meyer, Bukowski & Lioy, 
1998). Transferable chlorpyrifos residues have been found on children following 




Inhalation exposure can occur from the aerosols and vapors associated 
with spraying or fogging techniques. Crack and crevice treatments are applied 
where the insect is most likely to be found. Chlorpyrifos residues have been 
found in air samples for up to eight years following termite application (Wright, 
Leidy & Dupree, 1994). Broadcast applications have found chlorpyrifos residues 
up to 10 days following treatment (Currie, McDonald & Chung, 1990). Air 
residues were also collected for up to 30 days following the use of chlorpyrifos 
pest control strips (Jackson & Lewis, 1981). 
Because chlorpyrifos is extremely lipid soluble and therefore poorly 
eliminated, there is great concern that this chemical can be transferred from the 
pregnant woman to the developing fetus. In the developing fetus, the exclusive 
exposure pathway is transplacental transfer from the mother's blood circulation to 
the placenta. Because the placenta is a lipid membrane, lipid soluble chemicals 
that are nonionized with low molecular weights rapidly cross the placenta to the 
fetus. Evidence of anticholinesterase insecticide transfer (eg. organophosphates 
and carbamates) has been substantiated in the literature by measurements of 
cholinesterase inhibition in fetal tissues (Gupta & Sastry, 1995; Lassiter, Barone, 
Moser & Padilla, 1999). Whyatt and Barr (2001) also provided evidence of 
organophosphate placental transfer in their study of newborn meconium. 
Chlorpyrifos metabolites were found in 95-100% of meconium samples collected 
from the diapers of 20 newborns. 
Lactational transfer pathway. The lactational transfer pathway is another 





accumulate in maternal fat reserves and then be mobilized through lactation and 
transferred to the nursing infant through the process of depuration (Groer, 
Humenick & Wilson, 2002). In this process, lipophilic compounds can be 
released from storage depots or fat deposits and then released back into 
circulation, allowing them to be taken up into the fat of the mammory gland 
(Clewell & Gearhart, 2002). There are approximately 50 environmental 
contaminants that have been detected in human milk (Giroux, Lapointe & Baril, 
1992). Since breast tissue has a high fat content, it is possible that chlorpyrifos 
is transferred to the infant during lactation, thus becoming an excretion pathway 
for the mother. The transfer of chemicals from maternal blood to breast milk is 
dependent upon the following factors: the chemical, the mother, the milk, and the 
infant. 
The factors associated with chemical transfer include: 1) lipid solubility, 2) 
molecular weight, 3) protein binding, and 4) degree of pH ionization (Pons, Rey & 
Matheson, 1994). Lipid soluble chemicals partition into cell membranes more 
rapidly than water soluble chemicals in that they rapidly dissolve into the lipid 
bilayer. This process is known as the lipid (or octanol): water partition coefficient. 
Unlike plasma, breast milk contains emulsified fat (approximately 3.2 to 3.6%) 
that can concentrate lipid soluble molecules (8yczkowski et ai, 2001). 
The mammary epithelium membrane is semipermeable in that it allows 
chemicals of low molecular weights passage through the membrane. Generally, 
chemicals that have a molecular weight of 200 or greater have difficulty crossing 




into breast milk (Black, 1996). Larger chemical molecules may be transported 
biologically active into the alveolar cell by pinocytosis (engulfing of liquids or 
particles) and then released into the milk by apocrine secretion (Institute of 
Medicine, 1991). 
Chemicals are transported in the bloodstream unbound or partly bound to 
blood components (plasma or proteins). Only those chemicals that are not 
protein bound can leave the maternal circulation and diffuse across the cell 
membrane. By binding to proteins, chemical molecules become trapped and 
unavailable for lactational transfer. Breast milk contains several proteins; 
however, none of the major proteins tend to bind chemicals (Clewell and 
Gearhart, 2002). The lipid soluble chemicals are most often stored in adipose 
tissues and are in exchange with the circulatory system to reach equilibrium. This 
results in the toxicant being mobilized into the blood for further distribution and 
elimination or being redeposited in other adipose tissue. 
The degree of ionization is the final factor associated with the chemicals 
transferability into breast milk. Most chemicals are either weak acids or weak 
bases and exist in either an ionized or non-ionized form (Harvey & Champe, 
1992). Weak bases are nonionized in plasma which increases their lipid solubility 
and transferability into breast milk. This degree of ionization determines the 
percentage of un-ionized molecules that can cross the membrane (Wilson, 
1981). Distribution of an ionized molecule is determined by its pKa (the pH at 
which concentrations of non-ionized and ionized forms of the chemical are 
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equal). For a weak acid, the higher the pH, the lower the ratio of unionized to 
ionized forms. The opposite is true for a weak base. The lower pH of milk (6.8 
compared to plasma at 7.4) allows some weak bases to become ionized 
preventing them from diffusing back across the membrane (Byczkowski, 2001). 
The chemical then becomes trapped with the possibility of achieving an even 
higher concentration in the milk. Therefore those chemicals that are lipid soluble 
with weak bases generally pass through the membrane easily, concentrate in the 
milk fat globules that then lead to a high ratio of the chemical in milk as 
compared to the plasma (Dorman et ai, 2001) 
Several maternal factors influence the risk of chemical concentration in the 
breast milk. These factors include the route of exposure, the amount of chemical 
absorbed into maternal circulation, maternal age and weight, number of births, 
and timing and duration of lactation (Barrett, 2001). The route of exposure will 
determine how much of the chemical will be absorbed and distributed to the 
target sites. Because most toxicants are accumulated over the lifespan, 
bioaccumulation would be expected to increase with age. Maternal weight or 
body fat contributes to the concentration of chemicals in the breast milk as 
persistent lipophilic toxicants are stored in fat deposits. First-born children who 
were breast-fed would be exposed to a higher concentration of toxicants than 
subsequent children (Furst, Kruger, Meemke & Groebel, 1989). Since the lipid 
content in breast milk varies according to feedings, those who nursed for longer 




nurse for short periods of time (Clewell & Gearhart, 2002). Lactation may be an 
efficient way to excrete the maternal body burden of such toxicants in that some 
species can reduce their body burden by as much as 60-80% (Byczkowski, 
2001). 
Lactational factors include milk composition, milk to plasma ratio, and 
blood milk barrier. The composition of milk changes according to the gestational 
age of the baby. Lactogenesis occurs around the time of delivery and is defined 
as the onset of copious milk secretion (Neville, Morton &Umemura, 2001). 
During stage 1 alveolar cells are differentiated from secretory cells. In stage 2 
(occurs day 2 or 3 to day 8 following birth) endocrine control switches to 
autocrine (supply-demand) control and milk secretion begins (Neville et ai, 2001). 
The first milk that is secreted is known as colostrum and contains large quantities 
of protective substances needed for the newborn. It is full of proteins, vitamins, 
and immunoglobulins. The next milk stage is commonly called transition milk as it 
occurs days 6-10. During this stage, immunoglobulin and protein content falls 
while fat and sugar contents rise (10M, 1991). Fat content during lactogenesis 
increases from 2.9% in the first week to approximately 4% in mature milk. In 
addition, the fat content in hindmilk is higher than foremilk, 4-6% and 1-2%, 
respectively. (Needham &Wang, 2002). 
Galactopoiesis (later than 9 days after birth) is referred to as the mature 
milk stage. Milk volume increases from a mean of 50 ml per day to approximately 
500 ml per day. The milk that comes at the beginning of the feeding is known as 
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the foremilk and has a high level of sugar, protein, vitamins and minerals and a 
lower level of fat. The hindmilk comes towards the end of the feeding and is 
much richer in fat. This diurinal variation is more likely due to the varying degrees 
of breast emptying as opposed to a variation in lipid synthesis (10M, 1991). 
The milk to plasma (M/P) ratio refers to the amount of chemical milk 
concentration compared to maternal plasma (Ito & Koren, 1994). The amount of 
chemical concentration in milk depends on its half-life in the plasma and the rate 
of transfer across the mammary epithelium membrane. Those chemicals with a 
short plasma half-life may not have time to equilibrate across the epithelium 
resulting in higher plasma concentrations and lower milk concentrations. The milk 
to plasma ratio is used to determine the extent of chemical excretion in the milk. 
Those chemicals with a low M/P ratio are less likely to cause adverse effects in 
the nursing infant; however, most environmental chemicals have higher ratios 
which is due to their lipophilicity, poor water solubility and small ionization 
potential (Berlin &Kacew, 1997). 
The infant factors associated with the risk of chemical toxicity include the 
frequency and volume of feedings, absorption and distribution of the chemical, 
and clearance of the chemical by the infant. Those infants that breastfeed eight 
times or more a day are more likely to have a higher chemical concentration than 
those that breast-feed only once or twice a day. For infants one to six months 
old, the EPA (1997) suggests using an average breast milk intake of 742 mllday. 
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Once inside the body, the chemical is distributed to target organs or 
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storage depots via the bloodstream. Since adipose and breast milk are 
considered lipid rich matrices, lipophilic chemicals tend to partition among the 
lipid stores in blood, breast milk, and adipose tissue on a 1:1: 1 basis (Clewell & 
Gearhart, 2002). Chemicals can also be deposited in secretory structures such 
as tears, saliva, sweat, and milk (Barr, Wang, & Needham, 2005). 
Effects Assessment 
Toxicokinetics is the study of how a substance gets into the body and 
what happens to it once in the body. The processes involved include absorption, 
distribution, biotransformation, and excretion. Toxicants that are absorbed 
through the gastrointestinal tract are carried by the blood directly to the liver and 
are subject to biotransformation or excretion by the liver. Those that are 
absorbed through the lung or skin enter the bloodstream with blood filtered by the 
liver and kidneys. Once chlorpyrifos is absorbed into the bloodstream it may be 
excreted, stored, biotransformed into a different chemical or metabolite, its 
metabolites may be excreted or stored, and/or it or its metabolites may interact or 
bind with cellular components (Ecobichon, 2001). If a chemical is biotransformed 
into hydrophilic metabolites then it becomes detoxified, or less toxic, and is more 
easily excreted by the kidneys. However, sometimes it can be biotransformed 
into metabolites that are more toxic than the parent compound, which is known 
as bioactivation (Ecobichon, 2001). 
The liver is the primary biotransforming organ due to its high concentration 




microsomal superfamily of isoenzymes that transfer electrons and thereby 
catalyze the oxidation of many chemicals (Wexler, 1998). Phase 1 reactions 
involve the formation of a new or modified functional group or a cleavage utilizing 
the following transformation reactions: oxidation, reduction, hydrolysis, and/or 
acetylation (Vale, 1998). Because most of the phase 1 chemicals do not possess 
enough hydrophilicity to be eliminated from the body, they must now go through 
a second phase. In phase 2 the new modified chemical is conjugated (joined 
together) with another substance to decrease its ability to cross cell membranes 
and increase its polarity, water solubility and thus excretion from the body (Vale, 
1998). 
Chlorpyrifos utilizes the cytochrome P450 monooxygenases to bioactivate 
the parent compound to the oxon or phosphate metabolites. Through oxidation, 
the parent compound can be oxidized to form the oxon derivative, remain 
unchanged, or form des-ethyl chlorpyrifos (Wessels, 2003). Each of these can 
inhibit cholinesterase to form trichloropyridonol (TCP) as a by-product, which is 
then usually conjugated and excreted (Wessels, 2003). However, in order for this 
insecticide to biotransform into a potent anticholinesterase inhibitor, it must 
convert from a thion (P=S) to an oxon (P=O) (Vale, 1998). If the phase 2 process 
gets over saturated with too much of the chemical, the pathway is unable to 
sufficiently transform the chemical and the level of the parent toxin builds or 
enters different pathway that can result in the production of a more toxic 
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Figure 1. The metabolic activation from chlorpyrifos to chlorpyrifos oxon 
Chlorpyrifos is a neurotoxic agent in that it causes damage to the cells of 
the central nervous system and the peripheral nervous system. The toxic action 
of chlorpyrifos is acetylcholinesterase inhibition (Joesten, Netterville & wood, 
1993). This chemical inhibits the enzyme acetylcholinesterase in the nerve 
endings, resulting in the accumulation of the neurotransmitter, acetylcholine. If 
cholinesterase activity is inhibited, acetylcholine does not break down in the 
synaptic cleft leading to an excessive transmission of nerve impulses at the 
neuromuscular junctions, both centrally and peripherally (Joesten, 1993). In the 
central nervous system, excessive accumulation can cause sensory and 
behavioral disturbances, incoordination, depressed motor function, and 
respiratory depression (Ecobichon, 2001). Peripherally, overaccumulation can 
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result in bronchospasm, dyspnea, bradycardia, muscle fasciculations, motor 
weakness, and paralysis (Ecobichon, 2001). 
In animal studies, chlorpyrifos inhibition of acetylcholinesterase activity 
has been measured at doses that are much smaller than the LOso (dose 
producing 50% lethality). The inhibition of acetylcholinesterase has been 
measured two weeks, one month, and six weeks after exposure (Cox, 1994). 
According to Cox (1994), "researchers believe that this is because chlorpyrifos is 
lipophilic (attracted to the non water soluble, fatty parts of body tissues) meaning 
that chlorpyrifos is stored but then released and transformed to chlorpyrifos oxon 
so that effects (measured in behavioral changes) occur over a long interval" 
(p.3). 
Infants and children have unique characteristics that make them more 
vulnerable to the toxic effects of pesticides. First, they grow and develop at a 
rapid rate and any chemical exposure could result in permanent or irreversible 
dysfunction (Bearer, 1995). Second, the immaturity of their metabolic pathways 
leaves them unable to detoxify such chemicals (Eskenazi, Bradman & Castorina, 
1999). Finally, chemical exposures early in life can result in lifelong diseases like 
cancer. Of particular concern is the belief that exposure to neurotoxic pesticides 
like chlorpyrifos can lead to chronic neurological diseases such as dementia or 
Parkinson's disease (National Research Council, 1992). The underlying 
molecular and cellular processes are vulnerable to disruption by toxicants and 
can cause irreversible adverse effects on body structure and function (National 
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Resource Council, 1993). The scientific community has taken a keen interest in 
the adverse effects of developmental exposures and outcomes. 
Developmental toxicity refers to adverse effects to the developing embryo, 
fetus, or neonate. The manifestations of developmental toxicity vary according to 
the timing of the chemical exposure and the underlying processes that are 
occurring at that time. Those manifestations include: death of the developing 
organism (embryolethality), malformation (teratogenicity), growth retardation 
(embryotoxicity) and/or functional deficits (Schmidt & Johnson, 1997). 
Functional deficits are of great concern because of the sensitivity of the 
developing brain and central nervous system. Chemicals reach this system by 
the blood circulation. Because the central nervous system is so well perfused, 
lipid soluble chemicals enter the brain and exert their toxicities rapidly. Exposure 
to toxins can result in a magnitude of effects from mental retardation to significant 
learning disabilities. Behavioral, mental, and motor deficits are among the 
possible adverse outcomes (Rogers & Kavlock, 2001). 
Because chlorpyrifos is a neurotoxic chemical, the anatomical 
development of the fetus and infant is extremely vulnerable to its harmful effects. 
The developing nervous system begins at three weeks of gestation and is not 
complete until approximately six months after birth (Eliot, 2000). With different 
regions of the brain developing at different times, there are vulnerable periods 
throughout neurogenesis. For example, neural tube closure occurs during early 
gestation, diencephalon and cerebellum growth peak at birth and 2 years of age, 
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synapse formation continues until age five, and myelination continues through 
adolescence (Eliot, 2000). 
Equally as important, the blood-brain barrier is not fully developed until six 
months of age and even then is only partially protective to toxins (Rodier, 1995). 
Prenatal chlorpyrifos exposure in rodents has been shown to inhibit DNA 
synthesis and reduce brain anticholinesterase activity, resulting in significant 
motor and learning deficits (Whitney, Seidler & Slotkin, 1995). Other studies have 
shown that low dose exposures to chlorpyrifos during pregnancy or immediately 
after birth can adversely affect the central nervous system, resulting in behavioral 
changes and/or learning problems later in life (Chanda, Harp, Liu &Pope, 1995; 
Hunter, Lassiter & Padilla, 1999; Muto, Lobelle, Bidanset & Wurpel, 1992; 
Timchalk, Nolan, Mendrala, Dittenber, Brzak & Mattsson, 2002). 
Statement of the Problem 
Infants and children differ profoundly from adults and are extremely 
vulnerable to environmental health hazards such as chlorpyrifos and other 
pesticides. Disastrous health effects can include mental retardation, behavioral 
changes, developmental delays and cognitive deficits. Unfortunately, very little is 
known about the acute or chronic effects of chemicals, such as pesticides used 
in the environment. As a result, the safety and well being of infants and children 
may be compromised. This situation is further complicated by the multiplicity of 
environmental contaminants, various exposure pathways and underlying disease 
processes. Due to major knowledge gaps and a lack of consensus on causal 






mention the ethical constraints associated with the use of human subjects. The 
result is an uneducated public and an exacerbation of chemical exposures. 
Pregnant women and nursing mothers can expose their babies without even 
knowing it. Although breast-feeding is the recommended method of nutrition, 
there is limited information on the types of pesticides that can be absorbed and 
excreted into the breast milk. Collecting and analyzing breast milk during the 
nursing stage of the infant will help in quantifying chlorpyrifos exposure. 
In June 2000, the EPA announced the decision to restrict the sale of 
chlorpyrifos because of the potential danger to children. As part of the phase out 
agreement, retailers were to cease the sale of chlorpyrifos-containing products 
after May of 2002. Unfortunately, they were free to put these products on sale to 
get them off their shelves. Most importantly, retailers were not required to recall 
the product or warn consumers of the potential dangers associated with product 
use. In addition, farmers can obtain this product for use on certain food crops 
(apples, grapes, and tomatoes) and professional pest control operators are able 
to use chlorpyrifos containing products for severe termite infestations and as a 
mosquitocide around homes and on golf courses. 
Purpose of the Study 
The purpose of the study was to determine the concentration of 









Environmental health hazards, such as poor air quality, lead exposure, 
and pesticide exposure, can affect the quantity and quality of life. Potential 
outcomes include cancer, neurotoxic effects, and functional limitations. To 
understand the complex relationship between health effects and environmental 
hazards, a theoretical approach is needed to guide nurse researchers toward the 
goal of a health-promoting environment. An integrative model of environmental 
health research has been developed by Dixon and Dixon (2002) to provide 
researchers with a framework for environmental health research. The model 
contains four domains of knowledge: physiological domain, vulnerability domain, 
epistemological domain, and health protection domain. Each domain has a 
unique interdisciplinary focus, yet all the domains are interrelated so that a 
change in one domain can initiate a change in another. 
The physiological domain is considered the starting point of the model. 
This domain is concerned with the physiological processes and associated 
human exposure effects from chemical agents in the environment. This domain 
asks the question "what is the problem?" and it utilizes toxicological and 
epidemiological methods of inquiry. The domain includes four elements: agents, 
exposure, incorporation, and health effects. Anything capable of causing disease 
is defined as an agent. Chemicals such as pesticides fall into this category. 
Exposure involves contact with an agent meaning that without an exposure there 
cannot be adverse effects. Pesticide exposures can occur through oral ingestion, 




exposures to multiple agents however; most researchers focus on one chemical 
and one type of exposure at a time. Incorporation refers to the accumulation of 
the agent into human body compartments. Researchers use biomarkers to 
measure accumulation and subsequent biochemical changes in the body. Health 
effects are the primary area of interest in the field of environmental health. 
Heavily researched areas include asbestos exposure and lung disease, lead 
exposure and encephalopathy, and ozone exposure and lung cancer effects. 
The vulnerability domain is concerned with the individual and community 
characteristics that lead to variation in environmental health risks. This domain 
asks the question "who is affected?" Individual characteristics that can affect risk 
include health or disease state, gender, and development. Those persons with 
preexisting disease states are particularly vulnerable since any type of chemical 
exposure can exacerbate their current disease state, especially those with 
chronic respiratory or cardiopulmonary conditions. Women may be especially 
vulnerable due to pregnancy and reproductive physiology. Infants and children 
are extremely vulnerable due to their immature organ development. 
The epistemological domain is concerned with personal thought and social 
knowledge as it relates to effects of the environment on health. This domain asks 
the question "how does everyone know about this?" Personal thought is 
associated with cognition and begins with an awareness that a potential 
environmental health risk exists. Some have a lack of knowledge and are 
unaware of potential risks while others have an alternate attitude in that 
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such an event could never happen to them. This domain utilizes qualitative 
(ethnographies) and quantitative (surveys) as methods of inquiry. 
The health protection domain focuses on those actions taken to reduce an 
environmental health risk. This domain asks the question "what do people do 
about it?" The elements associated with this domain are: concerns and a sense 
of threat about risk and potential health effects, efficacy and confidence in the 
ability to eliminate the potential risk or environmental health hazard either 
through avoidance or acting as a change agent to reduce the hazard. 
This model (figure 2) proposes a circular pattern in that each domain 
impacts the others. Due to the enormity of environmental concerns, Dixon and 
Dixon suggest concentrating on one or two domains for a research study. 
Therefore, this study focused primarily on the physiological and the vulnerability 
domains. With respect to the physiological domain, chlorpyrifos was the chemical 
agent of choice and maternal breast milk, plasma, and saliva were the 
specimens used for the exposure pathway. In the vulnerability domain, lactating 
and non-lactating women were the targeted sample population. 
T oxicokinetics is the study of how a chemical is absorbed into the body 
and what happens following distribution of the chemical to other body organs. 
This phase involves four processes: absorption (chemical enters the body), 
distribution (chemical moves from the site of entry to other areas of the body), 
biotransformation (the body transforms the chemical into metabolites), and 
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Figure 2. Conceptual model by Dixon and Dixon 
Toxicology concepts were incorporated into the study for better 
understanding of the dynamics concerning the use of pesticides in the 
environment. Toxicokinetics is the study of how a chemical is absorbed into the 
body and what happens following distribution of the chemical to other body 
organs. This phase involves four processes: absorption (chemical enters the 
body), distribution (chemical moves from the site of entry to other areas of the 
body), biotransformation (the body transforms the chemical into metabolites), and 
elimination (chemical or its metabolites leave the body). 
Absorption varies greatly with different chemicals and with different 
exposure pathways. The primary routes of exposure are the gastrointestinal (GI) 
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tract (exposure to residues on food products or contaminants in drinking water), 
the lungs (inhalation exposure), and the skin (dermal absorption). Once a 
chemical is in the bloodstream it may be excreted, biotransformed into 
metabolites, which then may be excreted or moved into fat stores, or the 
chemical or its metabolites may interact or bind with cellular components in 
various organs. For a chemical to move within the body, it must pass across cell 
membranes. Cell membranes consist of a phospholipid bilayer so that each 
molecule consists of a phosphate head (hydrophilic) and a lipid tail (lipophilic). 
Chemicals that are lipophilic, non-polar, and of low molecular weight are readily 
absorbed through the cell membranes of the GI tract, lungs, and skin. Lipophilic 
chemicals are hard for the body to eliminate and can accumulate to hazardous 
levels. Most lipophilic chemicals can be transformed into hydrophilic metabolites 
that can be excreted by the kidneys. When biotransformation results in 
metabolites of lower toxicity, the process is known as detoxification; however, 
when the metabolites are more toxic than the parent compound, the process is 
known as bioactivation. Once reaching the target site, the toxicodynamic phase 
occurs. This leads to a molecular biochemical response, which produces a 
physiological response leading ultimately to the adverse effect in the target 
organ. 
Based on the above information and an extensive literature review, the 
model below was developed to simplistically illustrate the various potential 
pathways of chlorpyrifos exposure to the mother and the fetus or infant. In this 
model there are two pathways of concern. Both pathways begin with maternal 
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chlorpyrifos exposure, which is then absorbed and distributed to various parts of 
the body. In the transplacental pathway, chlorpyrifos is metabolized by the liver 
and then distributed to the placenta via the uterine artery. In the breast milk 
pathway, chlorpyrifos is absorbed and then distributed to fat stores which are 
later mobilized for milk production in the duct glands of the breast and excreted 
through the breast milk. In both pathways chlorpyrifos is delivered to infant blood 
circulation and then distributed to the immature brain, possibly resulting in acute 
or chronic neurobehavioral effects. The following framework was used to guide 
















Because the study employed a form of research known as secondary 
analysis, this particular study was confined to the biological specimens that were 
collected for the previous research project. 
Limitations 
1. 	 The majority of the participants were Caucasian. Thus the findings are 
not generalizable to all lactating and non-lactating women. 
2. 	 The specimens were collected over a two year time frame and 
then used for different types of analysis, therefore, subsequent 
laboratory storage technique might have impacted the integrity of the 
specimens. 
3. 	 Due to the associated costs of using gas chromatography, 
a chlorpyrifos assay that was designed for water samples was 
used for the study. 
4. 	 Because women are exposed over the lifespan to many 
organophosphorus compounds that have similar chemical structures, 
the assay may not be able to differentiate between chlorpryifos and 
other related compounds. 
5. 	 The chlorpyrifos assay is a screening test only for which sampling 
error may significantly affect testing reliability. 
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6. Chlorpyrifos measurement is recorded in parts per billion, so it is 
possible that the amounts in the three biological specimens were 
below the level of detection. 
Significance 
This study attempted to determine whether the pesticide, chlorpyrifos can 
be transferred into human milk and subsequently nursing infants. The enormity of 
such a find is insurmountable in that nothing like this has been done to date. 
There is clear evidence that these substances can accumulate and remain in the 
body fat for prolonged periods of time; therefore, it is imperative that steps be 
taken to prevent such exposures from occurring. The onus is on the healthcare 









The purpose of this study was to determine the range of concentrations of 
chlorpyrifos in human breast milk, plasma, and saliva. This was a concern 
because of the potential of this chemical to interfere with infant development. 
Few studies have assessed pesticide exposure in infants and children, and no 
stud ies have examined potential adverse effects as a result of chlorpyrifos 
exposure. Therefore, a broad approach to the literature was taken to establish an 
empirical linkage between these concepts. The literature reviewed for this 
research concentrates on two distinct areas. The first section consists of 
literature that add resses the exposure pathways, specifically for the 
organophosphate chlorpyrifos. The second section will address the potential 
health effects associated with such an exposure. A summary of the literature 
review will conclude this chapter. 
Exposure Assessment 
Chlorpyrifos exposure can occur through multiple routes. Exposure to 
such a chemical is due to residues in food and water (oral exposure), skin 
contact with contaminated articles (dermal exposure), and dispersal of aerosols 
and vapors in the atmosphere (inhalation exposure). Other routes of exposure 
include the transfer of chemicals from a mother's placenta (transplacental 
exposure) and through the consumption of breast milk (lactational exposure). 
Oral exposure. Oral exposure occurs by children eating foods 
contaminated by chlorpyrifos residues. A major breakthrough in the analysis of 
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pesticide dietary exposure came from a report entitled "Pesticides in the diets of 
infants and children". This report was published in 1993 by the National 
Research Council. According to the report, not only were children being exposed 
to high levels of pesticide residues but they also had proportionately greater 
dietary exposures than adults. From this report, Congress enacted the passage 
of the Food Quality Protection Act in which pesticide residue levels in foods must 
be found to be safe for infants and children. This act also required the 
government to apply a ten-fold margin of safety to food tolerances for the 
pesticide. The organophosphate class of insecticides was one of the first groups 
of chemicals to be scrutinized under this new law. However, an analysis 
published in 1998 by the Environmental Working Group revealed that out of the 
80,000 samples of food inspected, 13 organophosphate insecticide residues 
were found. Chlorpyrifos was one of the thirteen. 
The Environmental Working Group study utilized surveillance data 
collected by the FDA and USDA on pesticide residues from the years 1992 
through 1996. The FDA has two separate surveillance programs, the FDA 
Pesticide Surveillance and Monitoring Program (PSMP) and the FDA Total Diet 
Study (TDS). In the PSMP program, approximately 12,000 to 16,000 food 
samples are tested from all regions of the country. Unfortunately, none of the 
food samples were obtained from crop growers known to have previous 
violations. The second program (TDS) tests 234 different foods quarterly from 
four grocery stores in one of four regions in the country. Unfortunately, the 





contaminants. Interestingly enough, out of 16 samples of wheat bread, all of 
them were positive for chlorpyrifos, malathion (another organophosphate), or 
both (EWG, 1998). The USDA Pesticide Data Program (PDP) monitors pesticide 
levels in fresh fruits and vegetables. Approximately 400-700 samples are taken 
from 12-14 crops per year. Unfortunately, all of the samples were washed and 
peeled prior to testing which may not accurately reflect actual consumer behavior 
prior to consumption. The samples with the most toxic levels of 
organophosphates were apples, peaches, grapes and pears (EWG, 1998). 
Chlorpyrifos has also been found as an illegal residue on food products for 
which its use has been prohibited. In 1990, the FDA found detectable levels of 
chlorpyrifos on fresh lettuce, a crop for which it was not registered for use. There 
were nine other pesticide residues found in domestically produced lettuce 
samples but the most frightening find was the chemical DOE, a byproduct from 
the breakdown of DDT. Even though the U.S. banned DDT in 1972, its 
persistence in the environment may account for its presence on certain food 
crops (Vandeman, Shank, Chandran, &Vasavada, 1992). 
Chlorpyrifos residues were also found in Cheerios. In 1994, the FDA 
discovered the residues on a sample from General Mills cereal. Further 
investigation revealed that a commercial pesticide applicator had illegally 
sprayed 21 million bushels of raw oats with a chlorpyrifos formulation that had 
not been registered for use. The fumigator pocketed $85,000 from the deal by 
using chlorpyrifos since it was less expensive. General Mills sold 110 million 
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boxes of the contaminated cereal before the rest was destroyed (Natural 
Resources Defense Council, 1994). 
In 2000, the EPA announced restrictions on the use of chlorpyrifos for 
certain food crops in the U.S.; however, many other countries have no such ban. 
From 1998 to 2003, chlorpyrifos residues were found on apples, oranges, 
grapes, pears, and grapefruits imported from the United Kingdom. Residues 
were found on 160/0 of supermarket apples and 33% of citrus fruit tested 
(Pesticides Residues Committee, 2004). Tomatoes imported from Mexico also 
had detectable chlorpyrifos residues in over 200/0 of samples tested (Benbrook, 
2000). 
Finally, chlorpyrifos residues were detected in 260/0 of freshwater fish, 
which included trout and catfish. The EPA Office of Water published a report 
citing the study in which fish were collected from 388 sites. The majority of the 
sites were near agricultural areas, paper mills and industrial plants (1992). 
Children may also be exposed to chlorpyrifos residues while exploring 
their environment by putting fingers, toys, and other objects into their mouths. In 
a study by Gurunathan et al (1998), two apartments were treated with a 
broadcast treatment of chlorpyrifos by a licensed pesticide applicator. Plastic and 
plush toys were placed on the floor one hour following the application. Residual 
analyses were performed at 8,24,72, 168, and 336 hours. According to the 
results, chlorpyrifos functions initially as an aerosolized particle, which is then 
deposited onto various surfaces. In the next phase, it releases from the surfaces 
as a vapor and is then absorbed onto the toys and furniture. The levels on the 
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plastic toys peaked immediately while the plush toys sustained increasing levels 
over a two-week period. The ventilation methods employed for this study were 
thought to coincide with those of a homeowner following label directions. The 
windows were kept closed immediately following application plus two hours. They 
were then opened for four hours and then remained closed for the duration of the 
study. Unfortunately, the researchers did not utilize different ventilation schemes 
to determine the various chlorpyrifos concentrations if a homeowner did not 
follow the label directions. Regardless, chlorpyrifos remained on absorbent 
surfaces for up to two weeks following application. 
Dermal exposure . .Dermal exposure occurs through skin contact with 
contaminated surfaces, such as carpets, house dust, and lawns or gardens. Lu 
and Fenske (1999) conducted a study in which chlorpyrifos residues were 
compared from carpet and furniture surfaces following broadcast and fogger 
applications. Two identical dormitory rooms were treated with chlorpyrifos, one 
with a broadcast application by a licensed pesticide operator and the other with 
an aerosol fogger. The ventilation techniques employed were according to 
labeled instructions. The twelve subjects recruited for the study were asked to 
press their hands into the treated carpet for one sample and then drag their 
hands on the treated carpet for another sample. Both samples were obtained 
three and a half hours following applications. These samples were then 
compared to wiped samples and cloth roller samples used on furniture in the 
rooms. According to the results, the transfer of chlorpyrifos from hand press and 
hand drag techniques were comparable between the two applications. The 
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residues from the carpet were substantially higher for the broadcast application, 
but the residues found in the fogged room were substantially higher on the 
furniture. Unfortunately, this study did not attempt to determine the amount of 
chlorpyrifos absorbed into the body from dermal transfer. 
Another potential route of exposure that can occur is through pets treated 
with chlorpyrifos containing products. In a landmark study by Boone, Tyler and 
Chambers (2001), two protocols were employed to determine the amount of 
potential transferable residues following chlorpyrifos flea and tick dips. The first 
group of twelve dogs was dipped according to the manufacturer's instructions for 
four consecutive treatments at three week intervals. The other group of twelve 
were dipped as above but were shampooed immediately after dipping. 
Chlorpyrifos samples were obtained by rubbing the dogs with cotton gloves. Both 
groups had fur samples collected prior to dipping, 4 hours after, and at 1,7, 14, 
and 21 days post treatment. According to the results, for group one, the dogs 
averaged 971, 157, 70, and 26 I--Ig of chlorpyrifos compared to the 
shampooed dogs that averaged 459, 49, 15, and 101--19, respectively. Most of the 
residues dissipated quickly after the first dipping (73-87%); however, the 
researchers concluded that if a 55-pound child pets the dog for just 5 minutes 
within 24 hours of the dipping, the child could be exposed to a potential dosage 
of 0.027-0.057 mg of chlorpyrifos or 0.0011-0.0023 mg/kg absorbed residues. 
The EPA has a safety limit of 0.003 mg/kg/day for all routes of chlorpyrifos 
exposure (EPA, 1988). The above predictions were calculated according to a 





estimates at best. This estimate does not take into account other variables such 
as surface area, the amount of clothing the child has on, or hand to mouth 
behaviors of the child; not to mention the potential for inhalation vapors 
associated with pet playing. Of course, most parents would not let their child play 
with the family pet within 24 hours of getting dipped?1 
Inhalation exposure. Inhalation exposure can occur in homes, day care 
centers, schools, playgrounds, and lawns treated with chlorpyrifos. Foggers, 
bombs, and aerosols appear to be the most readily inhaled due to their smaller 
particle size (National Research Council, 1993). Fenske, Black, Elkner, Lee, 
Methner, and Soto (1990) measured chlorpyrifos residues following a household 
broadcast application for fleas. In this study, a three-bedroom apartment was 
treated with a hand held broadcast nozzle by a licensed pest control operator. 
Opening windows and doors ventilated two of the three rooms. Air samples were 
obtained pre-application and then at five and 30 minutes, one, one and a half, 
three, five, seven, and twenty-four hours post application. Chlorpyrifos vapor 
concentrations (measured at 100cm above the carpet) were significantly higher 
at five hours (>60J,Jg/m3) to 24 (>40J,Jg/m3) hours post application in the non­
ventilated room and highest at seven (>10~g/m3) hours post application in the 
ventilated rooms. At 25cm above the carpet (considered the infant zone), the 
concentrations were significant for all three rooms at five (>60~g/m3 ventilated 
and >90~g/m3 non-ventilated) to seven hours (>50~g/m3 ventilated and 
>90~g/m3 non-ventilated) post application. Of most concern is that vapor 




ventilated or not, suggesting that infant/child exposure is most critical from five to 
greater than 24 hours following treatment. 
In 1998, Byrne, Shurdut, and Saunders were employed by 
DowAgrosciences to conduct a study evaluating chlorpyrifos exposure following 
crack and crevice treatment. In this particular type of application, an injector tip 
was used to streamline the insecticide directly to baseboards and cracks. For the 
study, the researchers used three different homes of comparable sizes and 
styles. The same licensed applicator treated all three rooms. Chlorpyrifos was 
applied to cracks between the baseboards and walls, under sinks, and behind 
large appliances. The windows remained closed during the application. 
Chlorpyrifos vapor samples were collected from the kitchen (treated) and family 
room (untreated) every day for up to ten days post application. At each location, 
the samples were collected at 40cm (child crawling zone) and 130 cm (standing 
adult) above the floor. In house #1, levels peaked between zero and two hours 
(0.76IJg/m3) at 130 cm above the floor in the kitchen. For house # 2, the peak 
concentration occurred at 60-72 hours (2.3 IJg/m3) and house # 3 at six to eight 
hours (1.7 IJg/m3) post application. Both peak concentrations occurred at the 40 
cm sampling height. In two of the three houses, the air concentrations declined 
eight hours after the application; however, in the third house, the levels peaked 
on day three and day six. The researchers are suggesting that this was due to 
the fluctuation of internal temperatures; however, according to the methods 
section, the air conditioning and heating remained off in an effort to maintain 




the researchers conclude that the daily 24 hour time-weighted average for the air 
concentrations at the 40 cm level were less than 1.6 IJg/m3 which is at least five 
times lower than the National Academy of Sciences guideline of 10 IJg/m3. 
Because the highest concentration lasted for only 12 hours and the air 
measurements decline over a seven-day period coupled with the fact that any 
actual inhaled dose would be rapidly metabolized and excreted, the researchers 
concluded that it is unlikely that there would be any cumulative effects for 
children following a crack and crevice treatment. Remember, the actual ceiling 
dose for children is 3 IJg/kg/day from all sources! 
Take-home exposures. Take-home exposures are a route of exposure 
that occurs from chlorpyrifos residues that are brought home on parent's work 
clothes or via farm proximity. Lu, Fenske, Simcox, and Kalman (2000) analyzed 
residential contamination of organophosphates in the homes of agricultural 
workers. Families were assigned to one of two groups. The first group consisted 
of families with at least one member employed as a pesticide applicator (#49) or 
as a farm worker (#13). The reference families comprised the second group and 
their eligibility criteria stipulated that no one could work or live closer than one-
quarter mile to a pesticide-treated orchard (14). All samples were obtained 
following the May- July spray season for tree fruit production. To analyze the 
take-home exposure pathway, wipe samples were obtained from the workers 
boots and the steering wheel. Hand wipe samples were obtained from the 
children with ages ranging from nine months to six years. According to the 




on one or more wipe samples. The majority of residues were found on the work 
boots. Ten out of 61 agricultural children had measurable levels of the same 
residues. None of the reference families had detectable residues on any of the 
samples collected. Unfortunately, there did not appear to be any determination of 
time between sample collection and pesticide application. Nor was there an effort 
to determine if working boots had been washed prior to the wipe sample. 
A similar study was conducted by Quandt (2004) in which 41 farm families 
were analyzed for pesticide residues. All of the families were Spanish and all had 
at least one child under the age of seven. Wipe samples were obtained from 
uncarpeted flooring, toys, and children's hands. The data collection occurred 
between June and December of 2001. According to the results, 44% of the floor 
samples, 29% of the toy samples and 22% of the hand samples had detectable 
levels of pesticide residues. The data collection used for this study was limited to 
peak spraying times. 
Transpiactentai exposure. Transplacental exposure is a new concern in 
infant/child exposures in that the potential transfer of chemicals from the 
pregnant mother to the fetus occurs in utero. In a landmark study by Whyatt and 
Barr (2000), meconium samples were collected from the diapers of 20 newborns. 
All of the samples were analyzed for six organophosphate metabolites: DEP 
(diethylphosphate) , DETP (diethylthiophosphate), DEDTP 
(diethyldithiophosphate), DMP (dimethylphosphate), 
DMTP(dimethylthiophosphate) and DMDTP (dimethyldithiophosphate). 





100% respectively in the meconium samples. Both of these are metabolites of 
chlorpyrifos and diazinon. Virtually none of the other metabolites were 
detectable. Interestingly, the researchers had no prior knowledge of prenatal 
pesticide use as the samples were collected randomly over a three-week period. 
This study suggests that exposures were most likely from the second trimester 
through delivery since meconium begins to collect around 16 weeks of gestation. 
Bradman (2003) wanted to determine early fetal exposures at 
approximately 15-20 weeks gestation by the use of amniotic fluid obtained during 
amniocentesis procedures. Amniotic fluid production begins immediately 
following embryo implantation and increases in volume throughout the pregnancy 
(Hytten &Chamberlain, 1991). Amniotic fluid samples were obtained from 100 
women who were referred for an amniocentesis in an effort to address potential 
genetic disorders. Twenty samples were used for method validation, and the 
remaining samples were divided into four sets of 20. The samples were then 
analyzed for synthetic pyrethroids, organophosphates, and other pesticides such 
as carbamates, herbicides, and chlorinated phenol metabolites. Twenty-five 
percent of the organophosphate group had detectable levels of DEP, DMP, or 
DMTP. Ninety percent of the samples had detectable levels of at least one 
chlorinated pesticide. There were not any detectable levels of any of the 
synthetic pyrethroids or herbicides in the samples. This study suggests that fetal 
exposures can occur as early as 15-18 weeks gestation which correlates with 
central nervous system development (Selevan, Kimmel, &Mendola, 2000). 




Finally, in the Children's Environmental Cohort study (2004), pregnant 
women were recruited from a prenatal clinic and two private clinics. Only 
primiparas with singleton births were selected for the study, which totaled 404 
participants. The researchers were interested in assessing the relationship 
between prenatal pesticide exposure, paraoxonase (enzyme) activity, and infant 
growth and neurodevelopment. Paraoxonase (PONI) is an enzyme that is 
important in the hydrolysis and deactivation of organophosphates (Costa, Cole & 
Furlong, 2003). A questionnaire was administered during the third trimester to 
ascertain potential pesticide exposures. Maternal blood samples and urine were 
also obtained during the third trimester, and cord blood samples were obtained at 
birth. The blood samples were used to analyze paraoxonase activity in the 
mother and infant. The urine samples were used to assess for the chlorpyrifos 
metabolite 3,5,6-trichloro-2-pyridinol (TCP). During hydrolysis, chlorpyrifos is 
detoxified and excreted in the urine as TCP. The infant birth outcomes used for 
the study included weight, length, head circumference and gestational age. 
Almost half of the participants (46.20/0) reported indoor pesticide use during the 
pregnancy. The only significant finding was the correlation between maternal 
paraoxonase activity, detectable levels of TCP in maternal urine and small infant 
head circumference. It was then hypothesized that since small head 
circumference has been associated with cognitive ability, chlorpyrifos could have 
a detrimental effect on infant neurodevelopment. 
Other studies have been done to determine pesticide exposures in 




use in pregnant women. Three hundred and fourteen African-American women 
were recruited for the study of which 72 consented to personal air monitoring. A 
pesticide questionnaire was administered to each woman in her home by the 
same researcher. Information was obtained on demographics, smoking and 
alcohol use and residential pesticide use. The 72 women that agreed to air 
sampling during the third trimester was asked to wear an ambient air monitor 
during the daytime hours for two consecutive days. From the questionnaire, 85% 
reported use of a pesticide during pregnancy. Most household uses were by 
sticky traps and gels; however, 35% reported the use of exterminators in the 
home and half of the homes were sprayed more than once a month. Alarmingly, 
9% reported using alternative illegal street pesticides, such as ''tempo'' 
(a pyrethroid) and "tres pasitos" (a carbamate). As for the personal ambient air 
monitoring, 100% of the women monitored had detectable levels of three 
pesticides: chlorpyrifos (range 0.7-193 ng/m3), diazinon (another 
organophosphate ranging from 2.0-6,010 ng/m3) and propoxur (a carbamate 
ranging from 3.8-1,380 ng/m3). Unfortunately, there was no prior determination of 
when the pesticide was used in the home prior to the personal air monitoring. 
Regardless, this is a significant finding for pregnant women' 
A similar study by Berkowitz et al (2003) investigated pesticide use by 386 
pregnant women. The questionnaire was also administered to the women during 
the third trimester to assess the use of pesticides by a household member, 
exterminator, fumigator, andlor pesticide applicator. Urine samples were also 




results, almost half (46%) stated that they or another household member had 
applied pesticides in the home during the pregnancy. The urinary metabolite TCP 
was (average 11.3IJg/g creatinine) higher than previously reported in other 
studies (2.2 IJg/g in the NHANES III survey by Hill et al and 4.6 IJg/g in the 
NHEXAS-MD study by Macintosh et al). 
Lactational exposure. Lactational exposure is a significant route of 
potential exposure in that infants can be exposed through contaminated breast 
milk. Lipophilic chemicals partition into maternal adipose tissue, and are then 
stored there for many years. Due to the rapid weight loss following birth, these 
chemicals can then be released back into circulation and taken up into the fat of 
the mammary gland (Clewell & Gearhart, 2002). Due to decades of toxic 
chemicals in the environment, contamination of breast milk is widespread 
throughout the country. These chemicals are stored in the fat component of the 
breast milk through the process of depuration. In this process, the fat comes from 
maternal fat stores and diet. 
In a landmark study by Brilliant et al. (1978), polybrominated biphenyls 
(PBBs) were measured in the breast milk of nursing mothers. PBBs and PBDEs 
(polybrominated diphenyl ethers) belong to a family of brominated flame­
retardants that are used in diverse products including electrical appliances and 
computers as well as in carpets and furniture upholstery. They most frequently 
enter the environment directly from broken capacitors. For instance, following the 
result of an industrial accident, several thousand Michigan dairy farms were 






meat and dairy products over a two-year period. The researchers conducted a 
random sample survey from 95 nursing mothers from the Upper and Lower 
Michigan peninsula. According to the findings, 43% of the women from the Upper 
Peninsula and 96% from the Lower Peninsula had detectable levels of PBBs in 
their breast milk. The authors estimate that approximately eight million of 
Michigan's nine million residents had detectable body burdens of PBBs. 
In 2003, Schecter, Pavuk, Papke, Ryan, Birnbaum and Rosen analyzed 
47 breast milk samples from a milk bank and community health clinic in Texas. 
The milk samples were from nursing mothers between the ages of 20 and 41 
years. The samples were analyzed for PBDE concentrations. According to the 
findings, all of the milk samples contained various levels of PBDE 
concentrations (6.2 to 419 ng/g) with a mean of 73.9 ng/g (parts per billion). The 
PBDE levels did not appear to vary according to maternal age, number of 
previous births, or length of lactation. 
Most recently (2004), the Environmental Working Group (EWG) conducted 
a survey to evaluate flame-retardants in breast milk. In their study, 20 healthy 
primiparous women were recruited to participate. The women were asked to 
collect a milk sample within several months following the birth of their first child 
and complete an exposure assessment questionnaire intended to obtain 
information concerning their lifestyle and home and work environments. The 
demographic information was as follows: 1) the participants were from 14 
different states in the US, 2) 18 were Caucasian, one Vietnamese, and one of 







five were former smokers but none smoked during pregnancy_ According to the 
results, every breast milk sample tested was contaminated with varying levels of 
PBDEs (9.5 to 1078 ng/g). In addition, the researchers reported finding two of the 
highest levels of PBDEs ever reported in human beings in the world (one worked 
in computer related research and the other was a registered nurse). One had 
recently replaced furniture cushions and the other had reupholstered dining room 
chairs. None of the participants reported unusual PBDE exposure so the 
variability in the PBDE levels was not easily explained by their diet, occupation, 
age, body mass or amount of time they breast-fed their infants. Interestingly, 17 
of the 20 participants had reported eating fish at least once per week, and 13 had 
reported eating fish in the week prior to collecting the sample. 
Cousins to the polybrominated biphenyl family are the polychlorinated 
biphenyls (PCBs) and the polychlorinated dioxins (PCDDs) and furans (PCDFs). 
PCBs were previously used mainly as heat transfer fluids in transformers while 
PCDDs and PCDFs were formed primarily as byproducts following incineration 
and metal smelting and refining. Wickizer, Brilliant, Copeland and Tilden (1981) 
analyzed PCB levels in 1,057 nursing mothers. The samples were obtained from 
68 of 83 Michigan counties of which all the samples contained PCB residues 
ranging from trace amounts to 5,100 ppm (parts per million). The mean PCB 
level was 1 ,496 ppm. 
In a four-year study of PCB contaminants, Rogan and Gladen (1985) 
collected breast milk samples from 856 mothers of which 43% were primiparous. 








They also reported a decline in the PCB levels by approximately 20% after six 
months with an average time for breast-feeding of 29 weeks. Unfortunately, they 
did not describe the data collection or data analysis in the paper. 
Additionally, in a study by Hong, Xiao, Casey, Bush, Fitzgerald and 
Hwang (1994), 50 breast milk samples were analyzed for PCBs from 20 women 
from the Mohawk reservation, which is in close proximity to an industrial facility, 
and 30 controls who resided elsewhere. The authors reported an association 
between breast milk PCB concentrations and age, parity, duration of lactation, 
and cigarette smoking. Those that were older, smoked and breast-fed their first 
child had higher levels of PCBs in the breast milk. 
Schecter, Ryan and Papke (1998) also reported finding a decrease in 
PCB concentration over the lactation period. In this study, the researchers 
collected 13 breast milk samples from a mother who was nursing twins and 
analyzed them for PCBs, PCDDs and PCDFs. In their findings, the PCB 
concentration decreased from 285 to 63 ng/g over two and a half years whereas 
the PCDD and PCDF concentrations decreased from 309 to 173 ng/kg (75%) 
and 21 to 9 ng/kg (83%) respectively. The authors concluded that based on 
mathematical calculations, approximately two-thirds of the PCDD concentration 
was transferred to the twins. The study is obviously limited by sample size. Other 
persistent organochlorine chemicals have also been found in human breast milk 
such as dichlorodiphenytrichloroethane (DDT) and its metabolite (DOE), dieldrin, 
heptachlor, and hexachlorobenzene (HCB). In the New York State Angler Cohort 
study (1996), researchers studied breast-feeding women who consumed fish 
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from Lake Ontario. The women were either licensed anglers or spouses of male 
licensed anglers, and their milk samples were analyzed for PCBs, DOE, and 
HCB. Nine out of 77 PCB congeners and DOE were found in all of the 100 breast 
milk samples with those that consumed fish from Lake Ontario having a 
significantly higher level of PCB residues than the non-fish eaters (Vena, Buck, 
Kostyniak, Mendola, Fitzgerald, Sever, Freudenheim, Greizerstein, Zielezny, 
McReynolds, &Olson, 1996). 
Schecter, Ryan and Papke (1998) not only reported PCBs, PCDDs and 
PCDF concentrations in their milk samples of the mother nursing twins but also 
DOE and HCB. The DOE concentration (246 to 46 ng/g) declined by 81 % over 
the 30-month lactation period. The HCB concentrations (10.7 to 1.8 ng/g) 
decreased 92% over the same time period. 
The only reported chlorpyrifos study was performed on maternal rats. This 
report (1998) was an analysis of twelve developmental neurotoxicity stUdies 
evaluated by the Office of Prevention, Pesticides, and Toxic Substances 
(OPPTS). The results of the studies were summarized and compared to related 
studies to evaluate prenatal development, reproduction, and neurotoxicity in adult 
rats. In one of the studies, pregnant rats were administered chlorpyrifos from the 
time of implantation until day ten of the lactation period. Blood and milk samples 
were collected on gestation day 20 and lactation days one, five, and eleven and 
then analyzed for chlorpyrifos and the two metabolites (chlorpyrifos oxon and 




days one and five were at least ten-fold higher than maternal blood 
concentrations (Makris, Raffaele, Sette, & Seed, 1998). 
A recent study by Sanghi, Pillai, Jayalekshmi, and Nair (2003) of human 
breast milk samples found several organophosphates including chlorpyrifos. In 
this Indian study, breast milk samples were collected from 12 mothers aged 19 to 
45 years. Among the mothers, three were primigravidae, and the rest had two to 
five children. The breast milk samples were collected by manual expression once 
the infant had nursed. Unfortunately, the authors did not provide any time line as 
to when the samples were collected. The samples were then frozen at -20°C. 
Data analysis was performed with the use of gas chromatography to determine t 
the presence of three organochlorines and three organophosphates. Among the 
various pesticide residues present, chlorpyrifos was the second highest 
concentration found in the breast milk samples. In addition, all 12 samples 
contained varying residue levels of chlorpyrifos. 
Biomarkers ofExposure 
Because fetuses, infants and children have so many potential exposure 
routes, biomarkers have now become the benchmark for determining such an 
exposure. Biomarkers for determining organophosphate exposure typically 
include cholinesterase inhibition (De Peyster et ai, 1993; Lessenger &Reese, 
1999; Vandekar, 1980) in blood and metabolites in urine (Adgate et ai, 2001; 
Castorina et ai, 2003; Fenske, 2002; Loewenherz et ai, 1997; Lu et ai, 2001; 
Mills, 2001). As noted earlier, organophosphates undergo chemical changes in 





double bond of the central phosphorus atom transforms from sulfur to oxygen. It 
is now a considered an "oxon" and is a much more potent inhibitor of 
cholinesterase enzymes. This process can be measured in red blood cells by 
determining the reduced cholinesterase activity or AChE in the blood. 
Unfortunately, AChE levels can vary between individuals and can fluctuate within 
individuals as a result of health conditions, such as pregnancy, diseases, 
medications, and illegal drugs (Lessenger & Reese, 1999). In addition, large 
doses of chemicals are required for significant inhibition to occur resulting in an 
insensitivity to low exposure levels (He, 1999). Chlorpyrifos can b~ measured 
directly in the blood by way of plasma or serum; however, because chlorpyrifos 
metabolizes in 24-48 hours, it is unlikely that sample collection would coincide 
with the exposure (WHO, 1996). 
The second chlorpyrifos reaction that occurs is hydrolysis which yields a 
diakylphosphate and a leaving group. This metabolic reaction is known as 
detoxification as it is easily excreted in urine as the metabolite TCP. The difficulty 
in measuring this metabolite and other organophosphate metabolites is related to 
the concentration of the urine. Most laboratories will normalize the concentration 
by using creatinine clearance or specific gravity; however, in children, this can be 
quite variable (O'Rourke et al., 2000). 
Newer methods such as that of testing meconium (Whyatt & Barr, 2002), 
amniotic fluid (Bradman, 2003), saliva (Timchalk et ai, 2004) and breast milk are 
serving as biomarkers of the future. "The use of meconium shows promise and 
further research could firmly establish it as a biomarker for organophosphate 
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exposure" (Wessels, 2003). Breast milk is an appropriate biomarker for exposure 
because chemicals (especially those that are extremely lipophilic) can 
accumulate in the fatty tissues for a number of years. 
Effects Assessment 
Due to the vulnerability of fetal, infant and child development, the brain 
and the nervous system are especially sensitive to the effects of neurotoxic 
chemicals, such as the organophosphate chlorpyrifos. Other manifestations of 
toxicity includes fertility problems, spontaneous abortion, fetal death, birth defects 
and delayed growth. Most of this evidence comes from animal studies that 
examined developmental neurotoxicity. The precise nature of these effects 
depends on the amount of the dose received, the toxicological properties of the 
chemical and the timing of the exposure with the critical windows of fetal, infant 
and child development. 
Animal studies are done by exposing various animals to a chemical and 
then evaluating the effects of such an exposure. In a landmark study by Muto, 
Lobelle, Bidanset and Wurpel (1992), pregnant rats were given chlorpyrifos on 
days 0 to 7 or days 7 to 21. For both groups, the rats were randomly assigned to 
receive 0.03 mg/kg, 0.1 mg/kg, 0.3 mg/kg or saline. Following delivery, the rat 
pups were evaluated for viability, birth weight, and general physical 
characteristics. They were then re-evaluated on day 16 for behavioral 
abnormalities and neurotoxicity. In another study, rat pups were either given 






days 6-10 for the second group. Both groups were then observed on day 16 for 
behavioral abnormalities and neurotoxicity. 
For the neurotoxicity evaluation, a rotating rod on which pups had to 
balance was used to determine the number of falls, with comparison between the 
two groups of chlorpyrifos versus saline. The incline test was used to determine 
motor activity, and general motor behavior was assessed using open field 
observation. The pregnant females that received the chlorpyrifos injections did 
not exhibit any overt signs of toxicity; however, all three chlorpyrifos doses 
caused a greater number of abnormalities than those pups that received saline. 
For the 0 to 7 day group, chlorpyrifos caused 770/0, 57% and 680/0 lethality and 
15%,66°.4> and 55% physical abnormalities. For the 7 to 21 day group, 
chlorpyrifos caused 17%, 22% and 38% lethality with only the latter dose causing 
any physical abnormalities. None of the pups from the saline infused groups had 
any lethalities or abnormal physical characteristics. Rat pups given 0.3 mg 
chlorpryifos!kg prenatally demonstrated significant neurotoxicity on postnatal day 
16 as well as those pups that received chlorpryifos on postnatal days 3, 10, or 
12. 
Chanda, Harp, Liu and Pope (1995) also demonstrated neurobehavioral 
effects in rat pups following chlorpyrifos injections. In their study, pups were 
place in a supine position and then measured to determine their ability to turn 
over (known as the righting reflex). Chlorpyrifos exposure greatly altered this 
reflex on postnatal day one. In a different study, Chanda and Pope (1996) found 




inhibited levels of AChE. Whitney, Seidler and Slotkin (1995) demonstrated that a 
single dose of chlorpyrifos given to one-day-old rats could cause significant 
inhibition of DNA synthesis in all brain regions within four hours of treatment. 
Human studies are done to assess the potential effects of chemicals after 
the exposure has occurred. Steenland et al. (2000) conducted neurologic tests 
on pest control operators who had worked as termiticide applicators from 1987­
1997 in 12 counties of North Carolina. Those that had worked for a year or more 
were recruited for the study until 200 participants were selected (exposed group). 
Half of these subjects were asked to bring a friend to serve in the nonexposed 
group. Another 100 state employees were recruited as well for a total of 200 in 
the nonexposed group. All participants were given the Neurobehavioral 
Evaluation, which consisted of a vibrotactile test, arm/hand tremor test, postural 
sway test, manual dexterity test, eye-hand coordination test, vision test, olfaction 
test, nerve conduction velocity, and neurological exam. In addition, the 
participants were given a questionnaire to assess neurologic symptoms. Urine 
and buccal swabs were taken to measure TCP and paraoxanase, respectively. 
In the exposed group, 191 termiticide applicators who had an average of 
2.4 years applying chlorpyrifos were compared to 189 non-exposed participants. 
The two groups did not differ significantly in the neurological exam; however, the 
exposed group did not function as well as the non-exposed group on a few of the 
neurobehavioral tests (postural sway test and the pegboard turning test). In 
addition, the exposed group reported significant differences on the questionnaire 





muscle strength. Those applicators that had more recent chlorpyrifos exposures 
had higher levels ofTCP (629.5 ug/ L) in their urine than the other applicators 
(4.5 ug/L). 
Kaplan, Kessler, Rosenberg, Pack and Schaumburg (1993) conducted a 
retrospective analysis of eight people exposed to chlorpyrifos following 
commercial application by professional exterminators. All eight report peripheral 
neuropathy while five of the eight experienced memory loss and cognitive 
slowing. The authors concluded that environmental contact with chlorypyrifos 
could cause sensory neuropathy and central nervous system dysfunction. This 
study is extremely limited by the small sample size. 
Zweiner and Ginsburg (1988) reviewed the medical records of 37 children 
that had been diagnosed with organophosphate toxicity. The ages of the patients 
ranged from one month to 11 years. A little more than half of the children were 
boys, and 62% of the poisonings occurred from April through September. All of 
the poisonings occurred at home and six cases involved chlorpyrifos. Ingestion of 
stored liquid was involved in three-fourths of the cases, and playing on the carpet 
or floor following application was involved in 14% of the cases. The most 
common signs and symptoms included miosis (73%), excessive salivation (70%), 
muscle weakness (680/0), respiratory depression (590/0), lethargy (540/0), and 
tachycardia (490/0). Three of the six chlorpyrifos cases were life threatening due 
to coma or respiratory arrest (Blondell, 1999). There were no deaths, and 






Sherman (1996) reported four cases of birth defects associated with 
,­
chlorpyrifos poisoning. The obstetrical history was reviewed in all four cases for 
incidence of infections, alcohol and/or illicit drug use, medications and smoking. 
Other evaluations included chromosomal analyses, family pedig rees and records 
of treating physicians. The only common element found in all four cases involved 
chlorpyrifos exposure during the pregnancy. Three of the mothers were exposed 
at home, and the fourth was exposed at work. Child #1 and child #3 are siblings 
and were both exposed to chlorpyrifos after the family used a flea fogger with 
child #1 and used a commercial operator who applied chlorpyrifos in the home 
with child #3. The mother of child #2 was exposed late in the first trimester after 
treating the home with chlorpyrifos, and the mother of child #4 was exposed at 
work early in her first trimester. According to the author, all four children had 
ventricular, eye, and palate defects as well as growth retardation. Three of the 
four children had hydrocephaly, microcephaly, mental retardation, blindness, 
hypotonia and other limb defects. Brain defects were remarkable for 
structural defects of the corpus callosum in two children, an enlarged chloroid 
plexus in one child and absence of the septum pellucidum in the fourth child. The 
author suggests that the pattern of defects in all four children is conclusive 









There is ample evidence in the literature that chlorpyrifos poses a 
significant threat to fetuses, infants and children. The various pathways of 
exposure are well documented as well as the potential for developmental 
neurotoxicity in animals and humans. However, what is lacking is the 
documentation of chlorpyrifos as a vehicle for transport from the lactating mother 
to the nursing infant and the subsequent effects, if any, in the infant or child. 
Even though the EPA has banned chlorpyrifos for home use, it is still being used 
agriculturally and by professional pest control operators as they see fit. Until 
more is known about the developmental effects of these chemicals, continued 
research is imperative. Although most experts agree that breast -feeding is the 
preferred nutrition for nursing infants, studies are needed to evaluate pesticide 
exposures through breast milk in order to protect the infant from adverse effects. 
With this type of information, breast milk monitoring programs could be put in 









The purpose of this study was to determine the concentration range of 
chlorpyrifos in human breast milk, plasma, and saliva. The research method 
employed for this study was an analysis of existing samples collected for the 
purposes of a prior study. The study design, sample, setting, protection of human 
subjects, instruments used, data collection, and data analysis will be described 
below. 
Study Design 
Evidence suggests that women are being exposed to environmental 
chemicals such as chlorpyrifos; therefore a quantitative methodology was to 
guide this study. With this approach, biological samples can be collected 
(empirical evidence) to obtain numeric information about chlorpyrifos 
concentrations that can then be analyzed by statistical procedures. Due to the 
ethical issues associated with testing humans for chemical effects, non­
experimental studies are the most common research methods for collecting data 
of this nature. The most logical design for this type of study would be that of a 
longitudinal nature. Once the basic question of exposure has been answered, 
then effects of chemicals on factors such as neurobehavioral indicators could be 
measured over a specified unit of time. Theorizing that chlorpyrifos exposures will 
have developmental effects on fetal organs, such as the brain, there is a 
possibility that negative cognitive and behavioral indicators might not present 







favor this type of research design, due to time constraints associated with a 
dissertation proposal, such a study was not feasible. Taking into consideration 
the element of time, a more feasible option was that of the cross-sectional 
design. This type of design is used when there is a desire to obtain information in 
an area about which little previous research has been done. According to Polit 
and Hungler (2002), "cross-sectional data can most appropriately be used to infer 
temporal sequencing under two circumstances 1) when there is evidence or 
logical reasoning indicating that one variable preceded the other, and 2) when 
there is a strong theoretical framework guiding the analysis" (p. 162). This 
particular type of method fit this research design well in that logical reasoning 
implies that a mother must first have been exposed to chlorpyrifos so that the 
concentration can then be measured in the breast milk. 
However, for chemical exposure studies, the route, timing, and extent of 
the exposure are often difficult to determine (Clewell &Gearhart, 2002). Virtually 
all exposure studies collect historical information regarding pesticide use, which 
are usually answered through questionnaires or interviews. Fenske, Bradman, 
Whyatt, Wollfe, and Barr (2005) found that subjects were best able to provide 
general information regarding the use of products, as in controlling weeds or 
insects, but not necessarily able to provide detailed information on specific 
chemicals. According to these researchers, 
In preliminary analyses of questionnaires administered by the Columbia 
center, women provided a pesticide product name for only 39% of the 




and, in particular, were very rarely able to identify the pesticide products 
,­
used by an exterminator. Further, pesticide products can have the same 
brand name but contain different active ingredients, further complicating 
use of questionnaire data in pesticide exposure assessments. In addition, 
the Mount Sinai center collected urine samples in the 3mtrimester of 
pregnancy, and found that approximately 70% of the women in the cohort 
had been exposed to pesticides, but no associations were found between 
the biological levels and pesticide questionnaire data. 
The researchers concluded that it is highly unlikely that questionnaire data alone 
can prove adequate for identifying pesticide exposure of women during 
pregnancy (2005). 
According to the National Children's Study (2005), pesticide exposures to 
the general population may be very difficult to assess because humans are 
generally exposed to low levels of environmental chemicals all the time, the 
exposures may occur without prior knowledge, and they may occur through a 
multitude of routes or pathways. Therefore, when assessing pesticide exposures, 
there is no single method that will capture all the needed exposure information all 
the time (Needham et ai, 2005). 
Another concern is related to the subject matter of this particular study, in 
that the determination of chlorpyrifos residues present in maternal breast milk 
may be of extreme concern to nursing mothers. Mothers will want to know not 
only if the chemical is present but also the potential ramifications associated with 
such a find. In addition, the potential horror those mothers may experience when 
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learning that they may have inadvertently poisoned their babies could be in and 
of itself a potential crisis. Due to the above concerns, a less obtrusive research 
method known as secondary analysis was employed for this study. 
Secondary analysis involves the use of existing samples, collected for the 
purposes of a prior study in order to ask a new research question that is distinct 
from that of the original work (Hinds, Vogel, & Clarke-Steffen, 1997). This type of 
analysis can be used to generate new knowledge or new hypotheses. The 
advantages to using secondary analysis are that it reduces the burden of subject 
recruitment and data collection and it allows wider use of data from potentially 
inaccessible respondents. The study partiCipants were told that the purpose of 
the original study was to learn more about stress and health during the early 
postpartum period. The benefits of the original study were to gain more 
knowledge about stress, health and immune function in lactating versus non­
lactating postpartum mothers. 
Sample Design 
The original research study explored the influence of lactation on stress 
and immunity in postpartum mothers. This was a non-experimental, cross 
sectional study funded by the National Institutes of Health. The specific aims of 
the study were: 1) to analyze perceived stress, stressful life events, mood states, 
levels of stress-associated hormones, and relationships among these variables in 
lactating compared to non-lactating women; 2) to analyze immune variables and 
occurrence and severity of symptoms of common infections in lactating 







and mood variables, immune variables, and incidences and severity of symptoms 
1 
of common infections in lactating and non-lactating women. The researchers 
measured levels of stress hormones (oxytocin, prolactin, cortisol), type 1 and 2 
cytokines, enumeration of selected lymphocyte subsets, proliferative responses 
of lymphocytes, levels of stress hormones, neopterin and immunoglobulin A 
concentrations in saliva. 
Sample 
A power analysis was conducted to determine the appropriate sample size 
needed to increase the likelihood of demonstrating significant results. For a 
power of 0.80, a significance level of 0.05 and a medium size effect (r=. 3), a 
sample size of 80 subjects for each group would be sufficient. Therefore, the 
researchers recruited 100 lactators and 100 non-Iactators for the study. 
Subjects were recruited from the postpartum unit of a local hospital, 
through the health department, and participating OB/GYN offices at the time of 
their first postpartum visit. The subjects were healthy mothers between the ages 
of 18 and 45 years old who were four to six weeks postpartum after delivery of a 
full term infant by an uncomplicated vaginal or cesarean delivery. Exclusion 
criteria included the following: under 18 or over 45 years of age, chronic mental 
or physical illnesses, medications that could influence immune function, serious 
complications during pregnancy, labor, or delivery. The subjects were visited 
either in their homes or at their health care providers office between four to six 
weeks postpartum. At the visit, the investigators collected the study 




The milk, saliva, and serum samples were placed on ice and transported to the 
lab within two hours of attainment. The serum was spun, aliquoted, and frozen at 
-20°C. The milk was spun at 6000 rpm, aliquoted and also frozen at -20°C. 
For the purposes of this dissertation, this researcher chose 52 subjects 
from the original study for use in a secondary analysis. The subjects were 
selected based on the availability of biological specimens. In the lactating group 
there were 26 each of matched breast milk, plasma and saliva samples and in 
the non-lactating group there were 26 matched plasma and saliva samples. A 
two group design was chosen to compare differences in plasma and saliva 
chlorpyrifos concentrations. Based on the literature, these two concentrations 
should be higher in the lactation group. 
Setting 
As mentioned previously, this researcher chose 26 lactating subjects and 
26 non-lactating subjects for secondary analysis of breast milk samples, serum 
samples and saliva samples. The analysis was conducted at the Walker 
Research Laboratory in the College of Nursing, University of Tennessee, 
Knoxville, under the direct supervision of Dr. Maureen Groer. This researcher 
performed all the analysis of the biological specimens. 
Protection ofHuman Rights 
Subjects were invited to participate in the original study through notices 
posted at the University of Tennessee Medical Center, the Knox County Health 
Department, and in participating physician offices. Nurses were available at all 





questions. Once they agreed to participate in the study, a written consent was 
obtained. The participants were given a packet that included an information sheet 
about the study, potential risks and benefits, data collection procedures, notice of 
rights to withdraw from the study at any time, email address and telephone 
number of the researcher, and a $50 gift certificate. To insure confidentiality, no 
names were attached to any specimens, questionnaire forms, or instrument 
packets. All of the completed forms and specimens are kept in the Walker Lab, 
which is locked at all times. 
For purposes of the secondary analysis study, this researcher maintained 
confidentiality by assigning numbers to the questionnaires and biological 
specimens. The groups were categorized as lactators and non-Iactators. 
The information from the analysis was kept in a locked cabinet at the researchers 
home. Any published material will only contain the above information. 
Instruments 
The demographic tool was the only instrument accessed from the original 
study for use in this study. This questionnaire included information on age, race, 
height and weight, yearly income, family size, work status, exercise, presence of 
any acute or chronic health problems, smoking, medication use. It also included 
information on labor history, birth history, postpartum complications, and breast­
feeding or bottle-feeding status. 
Biological testing has become the template for determining human 
pesticide exposure. Because pesticide exposures have multiple routes, 





estimating the amount that is absorbed into the body and then measuring the 
pesticide itself, its metabolite, or its reaction products in biological media, such as 
urine, blood, saliva, meconium, and breast milk (Barr & Needham, 2002). Most 
persistent pesticides are best measured in such media as a result of their long 
biological half-lives and ability to sequester into lipid rich matrices. According to 
Barr and Needham (2002), because of the long half-lives of persistent pesticides, 
it is usually difficult or impossible to distinguish recent exposures from exposures 
that occurred decades ago. One possible indicator of a recent exposure may be 
a level elevated above the range that is normally seen. However, many 
chemicals and/or their metabolites are present in different concentrations in 
different types of biological media. 
The most common biospecimen for use in analyzing chemical exposures 
is urine. Such analysis is due to its ease in availability, the volume, and 
potentially higher concentrations (ug/I or parts per billion) as compared to blood 
concentrations (ng/l or parts per trillion). Unfortunately, the measurement is most 
often a metabolite of the parent compound. The other disadvantage to using 
blood for biosampling relates to the volume variability. Adjustments are required 
to correct for dilution issues, which often use creatinine concentrations. In the 
case of chlorpyrifos, there are several metabolites, such as DEP and DEPT, 
\that are the same metabolites as other organophosphates. The only metabolite 
that is specific to chlorpyrifos is TCP. The half-lives of chlorpyrifos and its 
metabolites in urine are 15 to 30 hours (Griffin et at, 1999). In the Minnesota 






from children aged 3 to 13. TCP was present in 930/0 of the samples. The 
metabolite TCP has been measured in urine as low as 0.5 ppb with a 
concentration range of 0.5 to 340 ppb of urine (Barr et ai, 2004a; Berkowitz et ai, 
2004; Chang, Lin, Lo, & Lin, 1996; Eskenazi et ai, 2004; Fenske, Lu, Barr, & 
Needham, 2002; Krieger et ai, 2001; Morgan et ai, 2004). Unfortunately, urine 
samples were not obtained from participants in the original study from which 
samples used in this study were derived. 
Measuring pesticides in blood is advantageous in that the parent 
compound, or its metabolites, can be directly measured in plasma and 
serum. Furthermore, because blood is a regulated fluid and does not vary 
markedly with water intake or other factors, no corrections for dilution are 
necessary (Barr & Needham, 2002). The half-life of chlorpyrifos in blood is 24 
hours (Nolan, Rick, Freshour, & Saunders, 1984). Chlorpyrifos concentrations 
have been detected in maternal and cord blood plasma with a range of <1 to 10 
ppt (Whaytt et ai, 2003; Whayett et ai, 2004). Chlorpyrifos metabolites have also 
been detected in plasma ranging from 0.1 to 2.8 ppm (Drevenkar et ai, 1994). 
Because chlorpyrifos is a potent inhibitor of acetylcholinesterase, the 
inhibition of cholinesterase is believed to be the most sensitive tool for evaluating 
exposure (Abdollahi, Mood, Akhgari, Jannat, Kebriaeezadeh, &Nikfar, 1996). 
This effect can be measured in red blood cells (AChE) and plasma (PChE). 
However, due to fluctuations in acetylcholinesterase levels, a baseline is usually 
required to determine if suppression has occurred (International Biomonitoring 





exposure levels are normally required to indicate acute toxicity and since most 
exposures are more likely to be intermittent, AChE might not be an appropriate 
measuring tool for chronic exposures (He, 1999). However, De Peyster, Willis, 
Molgaard, MacKendrick, and Walker (1993) found a high correlation between 
self-reported pesticide exposure and plasma cholinesterase activity for 203 
pregnant women. 
Saliva has recently received attention as a possible matrix for measuring 
pesticides. Scientists at the Department of Energy's Pacific Northwest National 
Laboratory found very low concentrations of chlorpyrifos in rat saliva (Kousba, 
Poet, & Timchalk, 2003). The researchers used a modified assay to assess 
salivary cholinesterase in male rats. In addition, Denovan, Lu, Hines, &Fenske 
(2000) reported saliva measurements of the herbicide atrazine in human 
pesticide applicators. The obvious attraction to this type of analytical 
measurement is that it is easy, cost-efficient and non-invasive. 
Breast milk has been shown to be an excellent source for evaluating 
pesticide exposures. Many organochlorine compounds have already been 
documented in human breast milk; however, there is only limited data available 
on any of the chemicals in the organophosphate class, especially chlorpyrifos. In 
a study by Mattson, Maurissen, Nolan, and Brzak (2000), chlorpyrifos and 
chlorpyrifos oxon analyses were conducted on milk from female rats that were 
exposed to chlorpyrifos via gavage. The samples were taken on lactation days 
one, five, and eleven. According to the authors, not only were chlorpyrifos milk 




measurable exposure to chlorpyrifos via the milk. Chlorpyrifos has also been 
detected in human breast milk according to a study from India. The mean 
chlorpyrifos concentration in 12 breast milk samples obtained during the first 
month of lactation from Indian women was 230 ug/L (ppb) with a range of 85 to 
355 ug/L (ppb) (Sanghi, Pillai, Jayalekshmi, & Nair, 2003). 
Scientists have been using gas chromatography for pesticide analysis 
because of its ability to detect low levels at extremely low concentrations; 
however, this particular type of method is expensive and requires skilled analysts 
for sample preparation. The need for rapid, cost effective monitoring methods to 
assess human exposures to environmental contaminants such as chlorpyrifos 
have been brought to the forefront by various research laboratories. 
Immunochemical methods such as immunoassays provide information regarding 
the presence and concentration levels of various environmental contaminants. 
This analysis is more time efficient and cost effective than other laboratory 
analyses such as gas chromatography. 
Immunoassays, used to detect and quantify many various types of 
molecules, which vary widely in size, chemical properties and biological activity, 
are sensitive, accurate, and reproducible. Most pesticides are rather small 
molecules and are typically less than 1,000 atomic mass units. Unless they are 
bound to an antigen, they will not bind to a specific antibody. Therefore, they 
must be conjugated to a larger protein molecule before they can be used as 
antigens. Fortunately, several research laboratories have developed selective 





ELISAs are based on selective antibodies combined with enzyme reactions to 
detect low levels of chemicals and was the method of choice used in this study. 
Chlorpyrifos RaPID Assay utilizes the principles of an immunoassay 
developed for the purposes of chlorpyrifos detection in water, wastewater, cereal 
grains, bananas, and soil. Even though the method had not been used for 
biological samples, the ease of the test and the minimal cost of the assay made it 
extremely attractive. A test kit was purchased from Strategic Diagnostics Inc. and 
a pilot test was run on five samples each of plasma, saliva and breast milk that 
were spiked with varying amounts of chlorpyrifos. Based on previous human 
biological studies of chlorpyrifos, this researcher spiked the samples with 0.1, 
0.5, 1.0, and 5.0 nanograms per milliliter (parts per billion) (Drevenkar et ai, 
1994; Sanghi et ai, 2003 & Whyatt et ai, 2004). The lowest concentration of 
chlorpyrifos the assay was able to detect was 0.1 ppb with a linear range was 
0.22 to 3.0 ppb. The assay is approximately eight times more sensitive to 
chlorpyrifos than any other related compound. 
The assay applies the principles of an ELISA (enzyme linked 
immunosorbent assay) by relying on antibodies that specifically detect 
chlorpyrifos and related compounds. To begin the test, 250 micrograms of 
standards (0.22, 1.0, and 3.0), control, and samples are placed into labeled test 
tubes. Chlorpyrifos enzyme conjugate (horseradish peroxidase labeled 
chlorpyrifos analog of HRP) is added to the test tubes followed by 500 
micrograms of paramagnetic particles. The chlorpyrifos antibody (mouse 





which are suspended in buffered saline. Both the chlorpyrifos in the sample and 
the HRP labeled chlorpyrifos compete for the binding sites on the antibody bound 
to the magnetic particles. Following incubation, a magnetic field is applied to hold 
the paramagnetic particles in place, which allows the unbound reagents to be 
decanted. After the decanting, the particles are washed with deionized water. 
The presence of chlorpyrifos is detected by adding a solution of hydrogen 
peroxide and chromogen (3,3', 5'5'-tetramethylbenzidine) in an organic base. 
These react to form a colored product. Following a second incubation, this 
reaction is stopped and stabilized by the addition of sulfuric acid. In the pilot 
test, the colorimetry results were evaluated with a photometer, which measures 
optical density (0. D.). Optical density values were then utilized to estimate 
chlorpyrifos concentrations using the standard curve O. D.s, with the GraphPad 
Prism software. All three biological samples responded accordingly in that the 
concentrations followed an appropriate linear curve based on the amount of 
chlorpyrifos spiked in the sample. The inter assay coefficients of variation for the 
breast milk samples were 18.56%. Based on this information, more kits were 
purchased for analysis of the three biological specimens. 
Data Col/ection 
In the original study, once the participants volunteered to participate in the 
study, a packet of instructions, instruments, and containers were mailed to their 
home address. Between four and six weeks postpartum the mothers were either 
visited during the morning in their homes or at their health care providers office 




instructions, mothers were to collect a saliva sample and a milk sample (if breast 
feeding). For the saliva sample, they were instructed not to eat, smoke or brush 
their teeth one hour prior to collection. The timed five-minute saliva specimen 
was collected by drool methods into a container. For the breast milk sample, the 
mothers were instructed to wash their hands with an antimicrobial soap before 
collection. They were to collect five milliliters (approximately one teaspoon) of 
milk, either by hand or by use of a breast pump, after they finished nursing. This 
sample was to be immediately placed in the refrigerator. Once the trained 
investigator arrived, ten milliliters of venous blood was obtained by antecubital 
venipuncture and immediately placed on ice. Once the biological samples and 
paperwork were obtained, they were transported on ice to the laboratory. 
For this study, the assays were run in batches. At the time the assays 
were run, the chlorpyrifos kit and the specimens were allowed to thaw to room 
temperature. The standards, control, and specimens were set up in duplicates for 
all the batches for a total of 26 breast milk samples, 52 plasma samples and 52 
saliva samples (26 each for lactating and non-lactating subjects). The 
Chlorpyrifos RaPID Assay was performed according to the manufacturers 
instructions. Absorbance was measured using a photometer with a wavelength 
of 450 nm. 
Data Analysis 
Descriptive statistics were used to describe the sample characteristics and 
demographic variables of the sample population. Descriptive statistics were also 






in all three biological samples. Tests for normality were conducted to determine 
whether parametric or non parametric tests were appropriate for statistical 
analysis. The variables requiring log10 transformation were plasma and saliva 
chlorpyrifos concentrations for positive skewness. 
To examine for relationships between milk, plasma, saliva and the other 
variables, such as age, weight, height, race, income, work, number of 
pregnancies, number of live births, marital status, smoking, use of prescription or 
herbal medications and number of weeks postpartum at the time of data 
collection, a correlation matrix was performed. The Pearson Product Correlation 
and the Spearman Rho Correlation were both used according to the level of data 
measurement. An alpha level of .05 was the criterion used for statistical 
significance. All data analyses were conducted with the SPSS software program. 
To determine if there were any differences between the lactating and non­
lactating groups, a t-test between the means was performed using the 
independent samples t-test. The t-tests were run on plasma and saliva for both 
groups. An alpha level of .05 was the criterion used for statistical significance. 
Summary 
Sio monitoring or testing humans for pollutants is performed on urine, 
meconium, amniotic fluid, blood and saliva. Sometimes those particular samples 
can be invasive and harder to acquire. Human breast milk is easy to obtain, less 
intrusive, and can provide much needed information on environmental chemicals 












































CHAPTER FOUR I 
RESULTS 
! 
The purpose of this study was to determine the concentration range of 
chlorpyrifos in human breast milk, plasma, and saliva in lactating mothers as 
compared with plasma and saliva in non-lactating mothers. In this chapter the 
findings of the study will be presented in three sections. The first section will 
describe the sample demographics. The second section will report the 
chlorpyrifos concentrations in the breast milk, plasma, and saliva samples in the 
lactating group. The third section will report the chlorpyrifos concentrations in the 
plasma and saliva samples in the non-lactating group. 
Sample Demographics 
Based on biospecimen availability, there were a total of 26 subjects each 
for the lactating and non-lactating groups. For the lactating group there were 26 
breast milk samples, 26 plasma samples and 26 saliva samples. The non-
lactating group had 26 plasma samples and 26 saliva samples. The mean, 
standard deviations and range were used to describe the variability in the 
samples. 
Tests of normality were performed on the means of all three biological 
samples, the breast milk, plasma and saliva. The milk variable was normally 
distributed. (Figure 4) However, the plasma and saliva variables were positively 
skewed. After verifying the data entries, four plasma chlorpyrifos values and 
three saliva chlorpyrifos values were identified as greater than three standard 
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Figure 6. Saliva chlorpyrifos concentration in parts per billion (ppb) 
It is important to note that 7 out of 52 plasma and saliva concentrations 
were extremely high and were therefore deleted. This could be a significant 
finding in that those seven subjects could have had acute chlorpyrifos exposures 
resulting in abnormally high levels. This could be a significant finding in and of 
itself. 
The mean age for the lactating group was 28.28 years +/- 5.899 SO 
(range 19 to 38). The mean weight was 168.53 pounds +/- 40.31 SO (range 132 
to 320) and height was 66.12 inches +/- 3.00 SO (range 60 to 72). There was one 
African American and one Hispanic in the lactating group; the rest were 
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Caucasian. The mean income was $30,000 to $40,000 +/- 1.41 SD (range 
<10,000 to >40,000). The majority of the subjects did not work (15 out of 26), 2 
worked part time and 9 worked full time, and the majority of them were married 
(22 out of 26 married, 4 single). The mean number of pregnancies was 2.16 +/­
2.19 SD (range 1 to 12), and the mean number of live births was 1.85 +/- 1.43 
SD (range 1 to 8). There were two subjects who smoked, eleven who used 
prescription medications and six who used herbal medications. Seven of the 
subjects had cesarean sections, and the rest were delivered vaginally. The mean 
for the number of weeks postpartum at the time of data collection was 5.16 +/­
.845 SD (range 3.6 to 7.0) (Table 1). 
Table 1. Demographic statistics for lactating group 
Descriptive Statistics 































































The mean age for the non-lactating group was 22.84 years +/- 4.35 SO 
(range 18 to 35). The mean weight was 162.05 pounds +/- 32.39 SO (range 105 
to 205) and height was 64.15 inches +/- 3.12 SO (range 58 to 70). There was one 
African American in the non-lactating group, and the rest were Caucasian. The 
mean annual income was $10,000 to $20,000 +/- 1.31 SO (range <10,000 to 
>40,000). The majority of the subjects did not work (19 out of 26), 4 worked part 
time and 3 worked full time), and the majority of them were married (14 out of 
26), 11 were single and 1 divorced. The mean number of pregnancies was 1.96 
+/- .841 SO (range 1 to 4), and the mean number of live births was 1.81 +/- .749 
SO (range 1 to 3). There were ten subjects who smoked, four who reported 
current health problems, six who used prescription medications and one who 
used herbal medications. Six of the subjects had cesarean sections, and the rest 
were delivered vaginally. The mean for the number of weeks postpartum at the 
time of data collection was 5.15 +/- .914 SO (range 4.1 to 7.5) (Table 2). 
Table 2. Demographic statistics for non-lactating group 
Descriptive Statistics 

































































25 of 26 milk samples were positive for chlorpyrifos (mean 1.10 ppb +/­
.503 SO, when detectable the range was .32 to 2.29 ppb). 19 of 26 plasma 
samples were positive for chlorpyrifos (mean .119 ppb +/- .106 S0, when 
detectable the range was .019 to .296 ppb) and 10 of 26 saliva samples were 
positive (mean .186 ppb +/- .299 S0, when detectable the range was .066 to 
.972 ppb) (Table 3). 
Eight of the subjects in the lactating group were positive for chlorpyrifos in 
all three biological samples. Of these eight, the mean age was 29.37 years, 
mean weight 188.83 pounds and mean height 67.4 inches. Seven of eight 
subjects were Caucasian one was African American. The reported income was 
$20,000 to $40,000 but most of them did not work. The majority of the subjects 
was married and most reported one live birth. Only one smoked, two used 
prescription drugs and none of them reported use of herbal medications. The 
mean for the number of weeks postpartum at the time of data collection was 5.43 
weeks. 
Three Significant correlations were found in the lactation group (Table 4). 
These correlations were between milk chlorpyrifos concentrations and number of 
live births (r=. 517, p=. 007, N=26) (Figure 7); between plasma chlorpyrifos 
concentrations and height (r=. 478, p=. 021, N=23) (Figure 8); and between milk 





Table 3. Statistics for biological samples in lactating group 
Descriptive Statistics 



















Table 4. Spearman Rho Correlation matrix for lactating group 
Spearman's Rho Correlations 












































Correlation .517­ .097 - .342 - .198 1.000 
Coefficient 
Sig. (2-tailed) .007 .652 .088 .344 
N 26 24 26 25 26 
* Correlation is significant at the .05 level (2 - tailed). 
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Figure 8. Positive relationship of plasma chlorpyrifos concentration 
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Figure 7. Positive relationship of milk chlorpyrifos concentration 
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Figure 9. Positive relationship of milk and plasma chlorpyrifos 
concentration in parts per billion (ppb) 
Milk chlorpyrifos concentrations were not correlated with any other 
demographic variables [age (r=. 167, p=. 424, N=25), weight (r=. 185, p=. 448, 
N=19), race (r=-.311, p=. 121, N=26), income (r=. 105, p=. 625, N=24), work 
(R=. 005, p=. 979, N=26), marital status (r=. 371 t p=. 062, N=26), use of 
prescription medications (r=-.057, p=. 783, N=26) or herbal medications (r=-.039, 
p=. 853, N=25) or with the number of weeks postpartum (r=-.081, p=. 694, 
N=26)]. Milk chlorpyrifos concentrations were not correlated with salivary 
chlorpyrifos concentrations (r=-109, p=. 603, N=26). 
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To test for differences in chlorpyrifos concentrations between the three 
biological samples in the lactation group, the t-test for dependent samples was 
used. A paired samples t-test was performed on milk/plasma, milk/saliva, and 
plasma/saliva. Analysis showed that there was significantly higher milk 
chlorpyrifos concentrations than either plasma (t=9.734, df=23, p=. 000) or 
salivary concentrations (t=7.690, df=25 , p=. 000) (Table 5). The mean 
chlorpyrifos milk concentration was 1.06 ppb +/- .502 SO compared to the means 
for plasma chlorpyrifos .119 ppb +/- .106 SO and saliva chlorpyrifos .188 ppb +/­
.299 SO (Table 6). 
Table 5. Significance of difference in milk and plasma/saliva chlorpyrifos 
Paired Samples Test 
Paired Differences 








9.734 23 .000.74108 1.14109.473645 .096682.94108 
Milk-
Saliva .000.67017 1.16045 7.690 23.606918 .119026.91531 
Saliva ­







Table 6. Statistics for lactating group 
Paired Samples Statistics 







































In the non-lactating group, all but three of the plasma samples were 
positive for chlorpyrifos with a mean of .149 ppb +/- .111 SO (range .020 to .395 
ppb). Sixteen of the saliva samples were positive for chlorpyrifos with a mean of 
.044 ppb +/- .061 SO (range .008 to .230 ppb) (Table 7). Fourteen of the subjects 
in the non-lactating group were positive for chlorpyrifos in both plasma and 
salivary samples. The mean age was 22.15 years, mean weight was 157.5 
pounds (although five of the subjects did not report a weight) and mean height 
was 63.78 inches. Thirteen of fourteen subjects were Caucasian and one was 
African American. Most reported an income of $10,000 to $20,000 and most did 
not work. Half the subjects were married and most reported two live births. Five 
subjects smoked, four used prescription drugs and none of them reported use of 
herbal medications. The mean for the number of weeks postpartum at the time of 
data collection was 5.19 weeks. 
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III 
Table 7. Statistics for biological samples in non-lactating group 
Descriptive Statistics 













Fourteen of the subjects in the non-lactating group were positive for 
chlorpyrifos in both plasma and salivary samples. The mean age was 22.15 
years, mean weight was 157.5 pounds (although five of the subjects did not 
report a weight) and mean height was 63.78 inches. Thirteen of fourteen subjects 
were Caucasian and one was African American. Most reported an income of 
$10,000 to $20,000 and most did not work. Half the subjects were married and 
most reported two live births. Five subjects smoked, four used prescription drugs 
and none of them reported use of herbal medications. The mean for the number 
of weeks postpartum at the time of data collection was 5.19 weeks. 
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Fourteen of the subjects in the non-lactating group were positive for 
chlorpyrifos in both plasma and salivary samples. The mean age was 22.15 
years, mean weight was 157.5 pounds (although five of the subjects did not 
report a weight) and mean height was 63.78 inches. Thirteen of fourteen subjects 
were Caucasian and one was African American. Most reported an income of 
$10,000 to $20,000 and most did not work. Half the subjects were married and 
most reported two live births. Five subjects smoked, four used prescription drugs 
and none of them reported use of herbal medications. The mean for the number 
of weeks postpartum at the time of data collection was 5.19 weeks. 
Two significant correlations were found in the non-lactation group (Table 
8). These correlations were between plasma chlorpyrifos concentrations and live 
births (r=-. 433, p=. 035, N=24) (Figure 10) and between plasma chlorpyrifos 
concentrations and work status (r=-.518, p=. 009, N=24) (Figure 11). The more 
live births and the more the subject worked, the lower the plasma chlorpyrifos 
concentrations. 
To test for differences between the plasma and salivary concentrations in 
the non-lactation group, the t-test for dependent samples was used. A paired 
samples t-test was performed on plasma and saliva. Analysis showed that there 
were significantly higher plasma chlorpyrifos concentrations than salivary in the 
non-lactation group (t=-3.860, df=20, p=. 001) (Table 9). The mean chlorpyrifos 
plasma concentration was .153 ppb +/- .110 SO compared to the mean 






Table 8. Spearman Rho Correlation matrix for non-lactating group 
Spearman's Rho Correlations 
Work Live births Plasma 
Work 
Correlation Coefficient 



























* Correlation is significant at the .05 level (2 - tailed). 
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Figure 10. Negative relationship of plasma chlorpyrifos concentration in parts per 
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Plasma chlorpyrifos 
Figure 11. Negative relationship of plasma chlorpyrifos concentration 
in parts per billion (ppb) and work status 
Table 9. Significance of difference in plasma chlorpyrifos 
Paired Samples Test 
Paired Differences 
Std. 95% Confidence Interval 
Std. Error of the Difference 
Mean Deviation Mean Lower Upper t 
Saliva ­










Table 10. Statistics for non-lactating group 
Paired Samples Statistics 














To test for differences in plasma and salivary chlorpyrifos concentrations 
between the lactating and non-lactating group, a t-test for comparison of means 
for independent samples was used. The mean plasma chlorpyrifos concentration 
in the lactation group was .119 ppb +/- .106 SO compared to .149 ppb +/- .111 
SO in the non-lactation group. However, the mean salivary chlorpyrifos 
concentration in the lactation group was .186 ppb +/- .299 SD compared to .044 
ppb +/- .061 SO in the non-lactation group (Table 11). There was not a significant 
difference in plasma chlorpyrifos concentrations between the two groups. 
However, in the salivary chlorpyrifos concentrations, the Levene test did provide 
sufficient evidence of group difference (F=26. 74, p=. 000) so the equal variances 
not assumed test was used (t=2.356, df=27.36, p=. 026). There appears to be a 
significant difference in salivary chlorpyrifos concentrations between the two 
groups and based on the mean, the salivary concentrations in the lactation group 


























































































































































































































































































































































































































































































































This study was conducted to determine if an organophosphate insecticide, 
chlorpyrifos, was present in the breast milk, plasma, and saliva of lactating 
mothers in comparison to non-lactating mothers. Various pesticides, such as 
chlordane, DDT, dieldren and heptachlor, have already been documented in 
human breast milk. Because organophosphates, along with synthetic pyrethroids, 
comprise 700/0 of the insecticide market share, it was possible that chlorpyrifos 
may also be found in women's breast milk. The results of this study have shown 
that chlorpyrifos is present in breast milk, plasma, and saliva of lactating and 
non-lactating mothers in measurable concentrations. A discussion of the findings 
is presented in this chapter, followed by the implications for nursing and 
recommendations for future studies. 
The purpose of this study was to determine the concentration range of 
chlorpyrifos in human breast milk, plasma and saliva from lactating mothers 
compared to non-lactating mothers. The samples were chosen from a previously 
funded research study on stress and lactation. There were a total of 26 
participants in two groups: one from women who were exclusively lactating and 
the other from formula feeders. Overall, for the lactation group, milk chlorpyrifos 
concentrations were significantly higher than plasma or saliva. Plasma 
chlorpyrifos concentrations were significantly higher than saliva in the non­








higher in the lactation group_ 
Traditionally, environmental epidemiologists examine the association 
between exposures to pesticides and adverse health outcomes through risk 
assessment. This process involves a quantitative estimation of the environmental 
exposure and the subsequent entry into the human body_ In general, most 
pesticide studies collect historical information regarding pesticide use and 
exposure via questionnaires or interviews. Since this study involved the use of 
secondary analysis of biological specimens from a previous study, this 
researcher was not able to correlate pesticide exposure with the pesticide 
concentrations found in the three specimens. Even though chlorpyrifos exposure 
can be variable and can occur through multiple routes, pattern use of chlorpyrifos 
applications or other types of information could have been an important 
supplement to biological monitoring. For instance, an acute exposure might 
explain the difference in chlorpyrifos concentrations among the different 
specimens in a particular individual. Also, information such as WOrkplace 
environment or pesticide use during pregnancy would have been helpful in 
quantifying higher chlorpyrifos concentrations. Since over 400/0 of Tennessee's 
total land area is farmland, with cropland accounting for more than 630/0 
(Tennessee Agriculture, 2004), additional information such as proximity to 
agricultural fields would have also been important information. 
This study used quantitative analytical methodology, such as biological 





saliva and in measurable concentrations. Each biological sample was analyzed 
for chlorpyrifos using an ELISA that measured concentrations in parts per billion. 
The results validated that chlorpyrifos is present not only in breast milk but also in 
plasma and saliva as well. This is the first known publicized study of chlorpyrifos 
analysis in human breast milk in the United States, and it is the first publicized 
study to use an ELISA specific to chlorpyrifos for the analysis of human biological 
specimens. 
Virtually all laboratory studies utilize gas chromatography to assess low 
levels of environmental contaminants such as pesticides. Not only is this type of 
analysis extremely expensive but it also requires the use of skilled analysts. 
Therefore, there is a growing demand for reliable, cost effective methods for 
determining pesticide exposure by more efficient techniques. Following an 
extensive search, an immunoassay specific to chlorpyrifos was discovered for 
use in water, soil, cereal, and fruit. Even though this particular assay had never 
been performed with human body fluids, the assay performed appropriately when 
the samples were spiked with varying amounts of chlorpyrifos concentrations. 
The breast milk, plasma and saliva concentrations followed an appropriate linear 
curve based on the amount of chlorpyrifos spiked in the sample. 
Pre-analytic activities, such as specimen collection, transport, specimen 
handling and storage, and identification of patient information are important 
measures. Because this study used biological samples taken from a previous 










by the mother in collection of the breast milk or saliva samples. In addition, this 
researcher was unable to validate the manipulation or storage of the samples 
upon arrival to the laboratory. 
There are also quality assurance procedures to aid in the reproducibility of 
the assay guide. This includes accuracy and precision to ensure the validity of 
the assay results. Standards and controls were incorporated into every assay to 
ensure appropriate testing performance. In addition, several sample assays were 
run to determine the ability of the assay to consistently reproduce the same result 
from the same specimen. The interassay coefficient of variation was 1a.560/0 in 
the breast milk specimens sampled. 
There were several issues with the assay that were out of this 
researcher's control. For instance, the Chlorpyrifos RaPID Assay, states on the 
package insert that the test is unable to differentiate between chlorpyrifos and 
other related compounds that have the same phosphate moiety; however, 
according to the limit of quantification, the test is at least ax more sensitive to 
chlorpyrifos than any of the other compounds. In addition, the limit of detection 
(LOD) for this particular assay was 0.1 ppb with a linear range of 0.22 to 3.0 ppb. 
Therefore, it is impossible to determine if those samples with non-detectable 
concentrations were actually zero or simply below limits of detection of the assay. 
Unfortunately, it is not possible to compare the results of this assay to 
previous studies because all other reported chlorpyrifos studies used gas 





parent compound, some chlorpyrifos oxon and other researchers analyzed 
chlorpyrifos metabolites. For example, in the study from India, the researchers 
describe the use of gas chromatography as their instrument for organophosphate 
analysis, but they did not report how chlorpyrifos was analyzed. However, as in 
this study, the researchers did find 12 out of 12 breast milk samples positive for 
chlorpyrifos with a mean of .230 ppm +/- 0.024 SO (range .085 to 0.355 ppm). It 
is important to note the differing concentrations between the studies. Sanghi et 
ai, reported chlorpyrifos concentrations in the parts per million as compared to 
this and other studies of chlorpyrifos concentrations in the parts per billion. 
Because chlorpyrifos is used extensively in agriculture, particularly wheat and 
rice crops, this might explain the discrepancy in high concentration levels 
(Sanghi, Pillai, Jayalekshmi & Nair, 2003). 
Lactating Group 
In the lactation group, there were 26 samples each of breast milk, 
plasma and saliva. In this group, the findings were that 25 out of 26 (96%) breast 
milk samples were positive for chlorpyrifos, 19 out of 26 (73%) plasma samples 
were positive, and 10 out of 26 (380/0) saliva samples were positive for 
chlorpyrifos. The findings also show that there was significantly higher 
chlorpyrifos concentrations in milk than either in plasma or salivary 
concentrations. In addition, 8 out of 26 subjects (30%) were positive in all three 
biological samples. 






fat stores into the breast milk of a lactating mother. Lipophilic chemicals, such as 
chlorpyrifos, can accumulate in maternal fat reserves and then be mobilized via 
lactation through the process of depuration. This pathway, known as the 
lactational transfer pathway, depends on a number of factors such as the 
chemical itself, the mother and the milk. 
The penetration of a chemical across the cell membrane is dependent 
upon several properties of the chemical. These include among others, degree of 
ionization, molecular size, hydrophobicity, and binding to maternal plasma 
proteins. Chlorpyrifos is non-ionized and since breast milk is more acidic (pH of 
6.5 to 7.2) than plasma (7.5), chlorpyrifos concentrations should be higher in the 
milk since chlorpyrifos passes readily through the cell membrane. Diffusion into 
the cell membrane is also dependent upon the molecular size of the chemical in 
that the smaller the molecular weight, the easier it transfers into the lipid barrier 
of the cell. The mammary epithelium membrane is semi-permeable in that it 
allows chemicals of low molecular weight passage through the cell membrane. 
Chlorpyrifos has a molecular weight of 350.6 and thus is able to penetrate 
through the cell membrane. 
The most significant property associated with chlorpyrifos is its 
hydrophobicity, better known as its lipid solubility. Chemicals are able to partition 
into milk according to their lipophilicity or octanol: water partition coefficient. 
Chlorpyrifos has a high lipid solubility coefficient of 4.7 to 5.3 rendering it capable 





in the plasma. Finally, those chemicals that become bound to proteins in the 
-

blood become trapped and unavailable for lactational transfer. Both plasma and 
milk contain proteins but none of the major proteins in breast milk tend to bind 
chemicals. Therefore, lipid soluble chemicals, like chlorpyrifos, tend to be in 
continual exchange with the maternal circulation and the milk. 
Several maternal factors influence the risk of chemical concentration in the 
breast milk: the route of exposure, maternal age and weight, number of births, 
and duration of lactation. Because chlorpyrifos exposure can occur through all 
the various exposure scenarios (oral, dermal, inhalation, and take-home 
pathways), the assumption was made that all women are exposed to and 
accumulate this chemical over a lifetime. Based on this assumption, it makes 
sense that the amount of the chemical concentration would increase with age. 
However, there was no correlation between maternal age and chlorpyrifos 
concentration in any of the three samples. This finding might be explained in part 
because of the young age in this population. The average age was 28.28 years, 
which suggests that these mothers might not have had as much chlorpyrifos 
exposure in their lifespan. 
Weight was not correlated with chlorpyrifos concentrations either. 
Unfortunately there are virtually no studies regarding the absorption, metabolism, 
and excretion of organophosphate pesticides in pregnant women. For instance, 
does post pregnancy weight loss impact the amount of chemical excretion? 
Since body fat contributes to the concentration of chemicals in the breast milk, it 
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could be argued that any abrupt weight loss could create a physiological 
excretion response, not just to the breast milk but to all other secretory pathways 
as well (Le. hair, tears, sweat, fingernails, and saliva). Another possibility is that 
with sudden weight loss, the chemicals can be released back into circulation and 
thus into the fat of the mammary gland. Since seven of the subjects did not report 
a weight and another six subjects reported a weight greater than 180 pounds, it 
is possible that sudden weight loss had not occurred by the time of data 
collection. 
There was a significant positive correlation between plasma chlorpyrifos 
concentrations and height, despite the finding that there was not a correlation 
between plasma or milk and body mass index. Because seven subjects in each 
of the two groups did not report their weight, an explanation is that there might 
have been a correlation had that information been included. Also, since the 
subjects reported their own height and weight and the average weeks 
postpartum at the time of data collection was approximately five weeks, those 
weight measurements could have been taken following discharge from the 
hospital (four to five weeks earlier) or at their four week postpartum check (one 
week earlier), suggesting that their current weight might not have been truly 
reflected at the time of milk collection. 
Another maternal factor that can influence the chemical concentration in 
breast milk is parity. It has been established that lipophilic chemicals are stored 







chemical studies have shown that the concentration decreases with the number 
of children that are breast-fed. There was a significant positive correlation 
between milk chlorpyrfios concentrations and the number of live births. Because 
this study was dependent upon the demographic information attained from the 
original study, this researcher is not sure if the mothers were including their 
recently born infant as a live birth since the average number of live births was 
1.8. In addition, there was not any information regarding feeding type with any 
previous children so it is impossible to know whether this particular infant was the 
first to be breast-fed or whether this factor might influence the results of this 
study. 
Factors that influence chlorpyrifos in breast milk include milk composition 
and milk to plasma ratio. The composition of milk changes according to the 
gestational age of the infant. Just as chlorpyrifos concentration decreases with 
the number of nursed children, so does the amount of chlorpyrifos over the 
course of lactation. As a mother breast-feeds, the concentrations of chemicals in 
breast milk decline over the weeks and months of lactation. 
Changes in the fat content of breast milk can occur during a feeding, from 
feeding to feeding, and over time. Since lipophilic chemicals pass into the milk, 
the fat concentration is probably the most crucial and variable of all factors. 
Lactogenesis II begins about 40 hours after birth and lasts approximately five 
days. The fat content during this stage is approximately 2.9%. The next stage of 
milk development is the transitional milk and it generally lasts from day six to day 
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ten of lactation. During this stage, immunoglobulin and protein content starts to 
fall while fat begins to rise so that by full lactation (galactopoiesis), the fat content 
is approximately 4%. In addition, hind milk can have an overall higher fat 
concentration (4 to 6%) compared to foremilk (1 to 2%). 
Studies have shown that lactation is a functional excretion pathway for 
lipophilic chemicals and by four to six weeks, and in this study the measurable 
concentrations of chlorpyrifos has diminished. The average number of weeks 
postpartum at the time of data collection was approximately five weeks, and 
there did not appear to be a correlation between milk chlorpyrifos values and the 
number of weeks of lactation. The subjects were carefully scrutinized by the 
researchers as to their exclusivity to ensure that mothers were strictly bottle 
feeding or breast feeding and not supplementing with other sources of nutrition. 
In addition, lactating mothers were given an information sheet instructing them to 
collect their milk from the breast when finished nursing either by hand expression 
or breast pumping. The samples were to be collected in the morning between 
7:00 a.m. and 12:00 noon and then immediately placed in the refrigerator. 
However, since the information packets were sent out well in advance of data 
collection, it is impossible to know not only what time of day the milk samples 
were taken but also during what part of the feeding cycle milk samples were 
taken. In addition the variation in sampling time (Le. three to four weeks 
postpartum compared to five to seven weeks postpartum) could have played a 





The milk to plasma (M/P) ratio is 'an estimation of a chemical 
concentration in milk compared to its concentration in maternal plasma. 
Pharmacologists often use this ratio to estimate the amount of drug delivered via 
breast milk to the nursing infant. Those chemicals with a high M/P ratio are 
thought to have higher concentrations in the milk than in plasma, and those with 
lower M/P ratios are thought to be lower in milk and higher in plasma. Most 
chemical profiles that exhibit higher M/P ratios are very fat-soluble, have weak 
bases and small ionization potential. Since chlorpyrifos has the appropriate 
characteristics associated with a higher M/P ratio, this would explain the positive 
correlation between milk and plasma chlorpyrifos concentrations as well as the 
statistically higher milk chlorpyrifos values compared to plasma. 
Non-lactating Group 
There were 26 samples each of plasma and saliva in the non-lactation 
group. In this group, the findings show that 23 out of 26 (880/0) plasma samples 
were positive for chlorpyrifos and 16 out of 26 (610/0) saliva samples were 
positive. In addition, 14 out of 26 subjects were positive for both. The findings 
also showed that there were significantly higher plasma chlorpyrifos 
concentrations in this group. 
During pregnancy, many physiological changes occur in the mother as a 
result of the rapid growth of the fetus and reproductive organs. These changes 
directly influence the toxicokinetics (absorption, distribution, metabolism, and 








50%, resulting in an increased blood volume followed by increased chemical I 
I distribution. In addition, the amount of chemicals bound to plasma proteins also 
increases considerably. Therefore, fat body stores would be expected to mobilize 
with subsequent release into the circulatory system. This would explain the high 
plasma chlorpyrifos concentrations. It is theorized that the chemical in the 
adipose storage depot is in relative equilibrium with the concentration in the 
blood or plasma so that as the chemical is released into the blood, it is also being 
eliminated from the blood to maintain the equilibrium. According to Rozman and 
Klaassen (2001), 
The compartment where a chemical is concentrated can be thought of as 
a storage depot. Toxicants in these depots are always in equilibrium 
with the free fraction in plasma. As a chemical is biotransformed or 
excreted from the body, more is released from the storage site. As a 
result, the biological half-life of stored compounds can be very long. 
Because the pharmacokinetics for plasma and saliva are comparable to 
each other, it would seem logical that chlorpyrifos would behave similarly in both 
compartments. However, before any chemical circulating in the plasma can be 
excreted into the salivary duct, it must contain certain physicochemical properties 
that allow it passage into the lipophilic layer of the salivary epithelial cell 
membrane, such as lipophilicity and molecular size. Those chemicals with high 
lipid: water partition coefficients, and low molecular weights can influence 




permeating cell membranes through the aqueous pores and therefore expending 
no energy (Rozman & Klaassen, 2001). In a study of rats exposed to diazinon 
(another organophosphate with a similar chemical structure as chlorpyrifos), 
concentrations in saliva were consistently lower than those in arterial plasma. 
The authors suggest that this difference is most likely due to protein binding of 
diazinon in the plasma (Fenske, Lu, & Showlund-Irish, 2005). Since chlorpyrifos 
and diazinon are so chemically similar, this could explain the resultant 
concentrations in the two compartments. 
There were two significant correlations in the non-lactation group between 
plasma chlorpyrifos concentrations, live births and work status. The more live 
births reported the lower the plasma concentrations and those that worked part­
time had lower concentrations as well. It could be argued that fat stores were 
mobilized into the circulatory system and potentially excreted (kidneys, saliva, 
etc.) with each subsequent pregnancy and birth. In addition, those that worked 
part-time to full-time spent less time at home with subsequently less chlorpyrifos 
exposure. Again, since the subjects were younger in age, it is possible that their 
work environments were safer than home in that some may still have chlorpyrifos 
containing products in their garages or under their sinks. 
Analysis between the lactation group and the non-lactation group revealed 
significantly higher salivary chlorpyrifos concentrations in the lactation group. 
Since the lactation group had significantly higher milk chlorpyrifos concentrations 






saturated with chlorpyrifos. In addition, the fact that chlorpyrifos is so lipophilic 
and the fat in milk is higher than in saliva, would explain why the milk would 
contain higher concentrations than the saliva. 
Nursing Implications 
Based upon the findings of this study, it can be concluded that chlorpyrifos 
is present in breast milk in measurable amounts. If chlorpyrifos is present, then 
what other environmental chemicals are also present in breast milk? This begs 
the question, "What are these chemicals doing to our precious children?" Those 
questions can only be answered through future studies. 
The nursing profession has a unique opportunity to take the lead in 
addressing the health issues associated with environmental contaminants. All 
nurses need to be more educated with toxicology concepts and public health 
issues as this affects nurses at every level. Nurses need to become more 
involved in research endeavors so that we are armed with scientific evidence of 
health effects of chemical contamination and exposure. The results of this study 
alone could be a pivotal beginning in spurring bigger laboratories to test not only 
this chemical but also other chemicals like it. 
Breast is always best; however, mothers need to be aware of the 
associated dangers of this and other pesticides. Not only pregnant women and 
nursing mothers but also women everywhere need to be better informed of the 
potential effects of pesticide exposure throughout the lifespan. Of course, the first 





effects these chemicals could be having on their developing brains. However, 
another concern, which this paper did not address, is women's health issues, 
such as breast cancer, autoimmune diseases, and osteoporosis. Is there an 
increased propensity for women to develop breast cancer as a result of a lifetime 
of toxic poisons stored in their breast tissue? What about the women who do not 
breast-feed? Are these toxins getting excreted in other ways or are they stored 
continuously in the adipose tissue? Education is paramount, and unfortunately 
we can no longer leave the education role in the hands of the Environmental 
Protection Agency or in the hands of the professional exterminator. Now is the 
time to better educate our communities on the dangers of chlorpyrifos, diazinon 
or any other toxic chemical. We cannot wait until there is sufficient evidence to 
ban the chemical from use because as we now know, that is too late as it has 
already saturated itself into the soil, the water, and our ecological system. In 
summary, nursing can protect the health and well being of women, mothers and 
their infants by generating new knowledge via scientific findings, communicating 
the associated health implications and implementing this knowledge into nursing 
practice. 
Future Studies 
The future of a healthy tomorrow depends on the science of yesterday. 
We are walking petri dishes full of scientific evidence of environmental 
exposures. All one has to do is test. We cannot rely on animal testing to 




of these chemicals need to be tested on animals, retested on animals, and then 
tested again on animals until the scientific community is absolutely confident that 
a chemical does not pose a threat to our health. Even this study could be 
validated using gas chromatography so that more chemical assays could be 
developed to allow for easier and cost effective monitoring. 
Participation in a comprehensive breast milk-monitoring program is key to 
an informed public. This would allow for the development of standardized 
protocols for specimen collection and analysis worldwide. Dr. LaKind (2001) and 
associates have agreed unanimously to develop such a program so that women 
from various socioeconomic backgrounds and geographic locations can be 
tested under similar conditions. This testing would provide scientifically based 
information to breast-feeding women on the risks of various chemicals. 
It is imperative that studies be done on our children. In a study by Perea 
(2003), chlorpyrifos concentrations were strongly associated with decreased birth 
weight and body length in babies of African-American women living in New York 
City. Additional studies, not just those involving chlorpyrifos, need to be 
prospectively performed to assess cognitive motor deficits, IQ and developmental 
delays. 
Summary 
There is mounting evidence of pesticide contamination in the breast milk 
of lactating women. This study has contributed to this knowledge by documenting 







lactating women. Bio monitoring of human breast milk provides an easy way to 
determine the body burden of lipophilic chemicals such as chlorpyrifos. Our 
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